AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|17|200830696|Female|All other|2008-2012|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|21|200830696|Female|All other|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Anaplastic astrocytoma|2008-2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|164|200830696|Female|Anaplastic astrocytoma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40629892|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40090306|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39935998|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Anaplastic oligodendroglioma|2008-2012|~|~|~
0-19|~|~|~|Malignant|~|200830696|Female|Anaplastic oligodendroglioma|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Astrocytoma, NOS|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|428|200830696|Female|Astrocytoma, NOS|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|40629892|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|78|40090306|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|81|39935998|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|140|200830696|Female|Choroid plexus|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|40|200830696|Female|Choroid plexus|2008-2012|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40629892|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40629892|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40090306|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40090306|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39935998|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39935998|Female|Choroid plexus|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|80|39865121|Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|39998876|Female|Craniopharyngioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|398|200830696|Female|Craniopharyngioma|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|200830696|Female|Craniopharyngioma|2008-2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40629892|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40629892|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|40090306|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40090306|Female|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|39935998|Female|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39935998|Female|Craniopharyngioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Diffuse astrocytoma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|77|200830696|Female|Diffuse astrocytoma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40629892|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|220|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.7|0.6|Malignant|232|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
0-19|0.5|0.5|0.5|Malignant|974|200830696|Female|Embryonal/primitive/medulloblastoma|2008-2012|0.5|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|202|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|40629892|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.5|0.5|Malignant|191|40090306|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.5|Malignant|183|39935998|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|69|200830696|Female|Ependymoma variants|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200830696|Female|Ependymoma variants|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40090306|Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40090306|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39935998|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39935998|Female|Ependymoma variants|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Ependymoma/anaplastic ependymoma|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|425|200830696|Female|Ependymoma/anaplastic ependymoma|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40629892|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|40090306|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|39935998|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|85|200830696|Female|Germ Cell Tumors|2008-2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|179|200830696|Female|Germ Cell Tumors|2008-2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|40|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40629892|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|53|40629892|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|20|40090306|Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|38|40090306|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Germ Cell Tumors|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39935998|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|61|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Glioblastoma|2008-2012|~|~|~
0-19|0.1|0.2|0.1|Malignant|288|200830696|Female|Glioblastoma|2008-2012|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40629892|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|70|40090306|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|39935998|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|229|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|229|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.7|Malignant|260|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|271|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|61|200830696|Female|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|1304|200830696|Female|Glioma malignant, NOS|2008-2012|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.7|0.6|Malignant|247|40629892|Female|Glioma malignant, NOS|2010|0.5|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|21|40090306|Female|Glioma malignant, NOS|2011|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|292|40090306|Female|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|21|39935998|Female|Glioma malignant, NOS|2012|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Malignant|203|39935998|Female|Glioma malignant, NOS|2012|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|59|200830696|Female|Hemangioblastoma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200830696|Female|Hemangioblastoma|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|248|200830696|Female|Hemangioma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|200830696|Female|Hemangioma|2008-2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|40629892|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40629892|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40090306|Female|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40090306|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|39935998|Female|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39935998|Female|Hemangioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Local Extensions from Regional Tumors|2008-2012|~|~|~
0-19|~|~|~|Malignant|~|200830696|Female|Local Extensions from Regional Tumors|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|200830696|Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40576293|Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|300|200830696|Female|Meningioma|2008-2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|200830696|Female|Meningioma|2008-2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40629892|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40629892|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40090306|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40090306|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|61|39935998|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39935998|Female|Meningioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Mixed glioma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|75|200830696|Female|Mixed glioma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40629892|Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Mixed glioma|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|53|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|48|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|47|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|75|40576293|Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|40576293|Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|342|200830696|Female|Neoplasm, unspecified|2008-2012|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|86|200830696|Female|Neoplasm, unspecified|2008-2012|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|86|40629892|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40629892|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40090306|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40090306|Female|Neoplasm, unspecified|2011|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|61|39935998|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|39935998|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|107|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|40382360|Female|Nerve sheath, benign and malignant|2007|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|582|200830696|Female|Nerve sheath, benign and malignant|2008-2012|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200830696|Female|Nerve sheath, benign and malignant|2008-2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40629892|Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40629892|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|110|40090306|Female|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40090306|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|103|39935998|Female|Nerve sheath, benign and malignant|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39935998|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Neuroepithelial|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|29|200830696|Female|Neuroepithelial|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Neuroepithelial|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|135|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|130|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|690|200830696|Female|Neuronal/glial, neuronal|2008-2012|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|92|200830696|Female|Neuronal/glial, neuronal|2008-2012|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|132|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|142|40629892|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|40629892|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|140|40090306|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40090306|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|39935998|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|39935998|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Oligodendroglioma|2008-2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|96|200830696|Female|Oligodendroglioma|2008-2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|40629892|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40090306|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|39935998|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|133|200830696|Female|Other mesenchymal|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|32|200830696|Female|Other mesenchymal|2008-2012|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|26|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40629892|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40629892|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40090306|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40090306|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39935998|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39935998|Female|Other mesenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|328|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|315|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|310|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|330|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|325|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|200830696|Female|Pilocytic astrocytoma|2008-2012|~|~|~
0-19|0.8|0.9|0.9|Malignant|1718|200830696|Female|Pilocytic astrocytoma|2008-2012|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|340|40670476|Female|Pilocytic astrocytoma|2009|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|40629892|Female|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|0.9|0.8|Malignant|339|40090306|Female|Pilocytic astrocytoma|2011|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|350|39935998|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|27|200830696|Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|72|200830696|Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40629892|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40629892|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40090306|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|39935998|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|39935998|Female|Pineal parenchymal|2012|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|245|39865121|Female|Pituitary|2004|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|288|39998876|Female|Pituitary|2005|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|318|40165421|Female|Pituitary|2006|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|305|40382360|Female|Pituitary|2007|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|344|40576293|Female|Pituitary|2008|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|1809|200830696|Female|Pituitary|2008-2012|0.9|0.9|0.9
0-19|~|~|~|Malignant|~|200830696|Female|Pituitary|2008-2012|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|342|40670476|Female|Pituitary|2009|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|391|40629892|Female|Pituitary|2010|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40629892|Female|Pituitary|2010|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|367|40090306|Female|Pituitary|2011|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40090306|Female|Pituitary|2011|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|370|39935998|Female|Pituitary|2012|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39935998|Female|Pituitary|2012|~|~|~
0-19|1.7|2.0|1.8|Benign/Borderline|742|39865121|Female|Total|2004|1.7|2.0|1.9
0-19|3.1|3.4|3.3|Malignant|1295|39865121|Female|Total|2004|3.1|3.4|3.2
0-19|2.1|2.4|2.2|Benign/Borderline|900|39998876|Female|Total|2005|2.1|2.4|2.3
0-19|2.9|3.2|3.1|Malignant|1219|39998876|Female|Total|2005|2.9|3.2|3.0
0-19|2.1|2.4|2.2|Benign/Borderline|901|40165421|Female|Total|2006|2.1|2.4|2.2
0-19|2.9|3.2|3.0|Malignant|1214|40165421|Female|Total|2006|2.9|3.2|3.0
0-19|2.1|2.4|2.2|Benign/Borderline|918|40382360|Female|Total|2007|2.1|2.4|2.3
0-19|3.0|3.4|3.2|Malignant|1286|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.2|2.5|2.3|Benign/Borderline|964|40576293|Female|Total|2008|2.2|2.5|2.4
0-19|3.0|3.3|3.1|Malignant|1268|40576293|Female|Total|2008|3.0|3.3|3.1
0-19|2.4|2.6|2.5|Benign/Borderline|5065|200830696|Female|Total|2008-2012|2.5|2.6|2.5
0-19|3.0|3.2|3.1|Malignant|6234|200830696|Female|Total|2008-2012|3.0|3.2|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|991|40670476|Female|Total|2009|2.3|2.6|2.4
0-19|3.0|3.3|3.1|Malignant|1266|40670476|Female|Total|2009|2.9|3.3|3.1
0-19|2.4|2.7|2.6|Benign/Borderline|1053|40629892|Female|Total|2010|2.4|2.8|2.6
0-19|2.9|3.3|3.1|Malignant|1261|40629892|Female|Total|2010|2.9|3.3|3.1
0-19|2.4|2.7|2.5|Benign/Borderline|1030|40090306|Female|Total|2011|2.4|2.7|2.6
0-19|3.1|3.4|3.2|Malignant|1297|40090306|Female|Total|2011|3.1|3.4|3.2
0-19|2.4|2.7|2.6|Benign/Borderline|1035|39935998|Female|Total|2012|2.4|2.8|2.6
0-19|2.8|3.1|2.9|Malignant|1166|39935998|Female|Total|2012|2.8|3.1|2.9
0-19|0.2|0.3|0.3|Benign/Borderline|107|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|583|200830696|Female|Tumors of Cranial and Spinal Nerves|2008-2012|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200830696|Female|Tumors of Cranial and Spinal Nerves|2008-2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40629892|Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40629892|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|40090306|Female|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40090306|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|103|39935998|Female|Tumors of Cranial and Spinal Nerves|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39935998|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|186|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.8|3.2|3.0|Malignant|1198|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.8|3.2|3.0
0-19|0.4|0.5|0.5|Benign/Borderline|190|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
0-19|2.7|3.0|2.8|Malignant|1129|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.8
0-19|0.4|0.6|0.5|Benign/Borderline|198|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1147|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.0|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|225|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1221|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|217|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1213|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.8|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|1106|200830696|Female|Tumors of Neuroepthelial Tissue|2008-2012|0.5|0.6|0.6
0-19|2.9|3.0|2.9|Malignant|5879|200830696|Female|Tumors of Neuroepthelial Tissue|2008-2012|2.9|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|203|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.6|0.5
0-19|2.8|3.1|2.9|Malignant|1186|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.1|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|222|40629892|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
0-19|2.8|3.1|2.9|Malignant|1180|40629892|Female|Tumors of Neuroepthelial Tissue|2010|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|228|40090306|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1217|40090306|Female|Tumors of Neuroepthelial Tissue|2011|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|237|39935998|Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.7|0.6
0-19|2.6|2.9|2.8|Malignant|1106|39935998|Female|Tumors of Neuroepthelial Tissue|2012|2.6|2.9|2.8
0-19|0.7|0.9|0.8|Benign/Borderline|325|39865121|Female|Tumors of Sellar Region|2004|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|363|39998876|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|393|40165421|Female|Tumors of Sellar Region|2006|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|400|40382360|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|406|40576293|Female|Tumors of Sellar Region|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.0|1.1|1.1|Benign/Borderline|2207|200830696|Female|Tumors of Sellar Region|2008-2012|1.1|1.1|1.1
0-19|~|~|~|Malignant|~|200830696|Female|Tumors of Sellar Region|2008-2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|433|40670476|Female|Tumors of Sellar Region|2009|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|480|40629892|Female|Tumors of Sellar Region|2010|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40629892|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|448|40090306|Female|Tumors of Sellar Region|2011|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40090306|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|445|39935998|Female|Tumors of Sellar Region|2012|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|39935998|Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|492|200830696|Female|Tumors of the Meninges|2008-2012|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|42|200830696|Female|Tumors of the Meninges|2008-2012|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|98|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40629892|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40629892|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|99|40090306|Female|Tumors of the Meninges|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40090306|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|121|39935998|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39935998|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|39865121|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|76|39998876|Female|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|79|40165421|Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|71|40382360|Female|Unclassified Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|113|40576293|Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|16|40576293|Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|590|200830696|Female|Unclassified Tumors|2008-2012|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|89|200830696|Female|Unclassified Tumors|2008-2012|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|105|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|129|40629892|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40629892|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40090306|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|22|40090306|Female|Unclassified Tumors|2011|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|120|39935998|Female|Unclassified Tumors|2012|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|22|39935998|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|112|200830696|Female|Unique astrocytoma variants|2008-2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|81|200830696|Female|Unique astrocytoma variants|2008-2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|30|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|40629892|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40629892|Female|Unique astrocytoma variants|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40090306|Female|Unique astrocytoma variants|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|40090306|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|25|39935998|Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|39935998|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|19|210393524|Male|All other|2008-2012|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|32|210393524|Male|All other|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Anaplastic astrocytoma|2008-2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|200|210393524|Male|Anaplastic astrocytoma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42550225|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|41999118|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|41821254|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Anaplastic oligodendroglioma|2008-2012|~|~|~
0-19|~|~|~|Malignant|~|210393524|Male|Anaplastic oligodendroglioma|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|104|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Astrocytoma, NOS|2008-2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|498|210393524|Male|Astrocytoma, NOS|2008-2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|120|42550225|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|41999118|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41821254|Male|Astrocytoma, NOS|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|179|210393524|Male|Choroid plexus|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|50|210393524|Male|Choroid plexus|2008-2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42550225|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Choroid plexus|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41999118|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|41821254|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41821254|Male|Choroid plexus|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|42158997|Male|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42367071|Male|Craniopharyngioma|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|396|210393524|Male|Craniopharyngioma|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|210393524|Male|Craniopharyngioma|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42609915|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42550225|Male|Craniopharyngioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42550225|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|41999118|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41999118|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41821254|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41821254|Male|Craniopharyngioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Diffuse astrocytoma|2008-2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|92|210393524|Male|Diffuse astrocytoma|2008-2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41999118|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41821254|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.7|0.7|Malignant|275|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|317|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
0-19|0.7|0.8|0.7|Malignant|1512|210393524|Male|Embryonal/primitive/medulloblastoma|2008-2012|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|309|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|314|42550225|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|297|41999118|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|279|41821254|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|101|210393524|Male|Ependymoma variants|2008-2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|210393524|Male|Ependymoma variants|2008-2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42550225|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41999118|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41821254|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41821254|Male|Ependymoma variants|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|105|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Ependymoma/anaplastic ependymoma|2008-2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|550|210393524|Male|Ependymoma/anaplastic ependymoma|2008-2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|119|42550225|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|41999118|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|41821254|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|85|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|98|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|96|210393524|Male|Germ Cell Tumors|2008-2012|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|527|210393524|Male|Germ Cell Tumors|2008-2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|97|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42550225|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|111|42550225|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|41999118|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|41821254|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|108|41821254|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|73|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|66|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|65|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Glioblastoma|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|372|210393524|Male|Glioblastoma|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42550225|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|41999118|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41821254|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|230|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|218|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|236|42158997|Male|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|241|42367071|Male|Glioma malignant, NOS|2007|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|263|42541971|Male|Glioma malignant, NOS|2008|0.5|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|54|210393524|Male|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|1292|210393524|Male|Glioma malignant, NOS|2008-2012|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.5|0.7|0.6|Malignant|261|42609915|Male|Glioma malignant, NOS|2009|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.5|0.7|0.6|Malignant|263|42550225|Male|Glioma malignant, NOS|2010|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|247|41999118|Male|Glioma malignant, NOS|2011|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|41821254|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.7|0.6|Malignant|258|41821254|Male|Glioma malignant, NOS|2012|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|84|210393524|Male|Hemangioblastoma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|210393524|Male|Hemangioblastoma|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|41999118|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41821254|Male|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41821254|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|31|42158997|Male|Hemangioma|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|42367071|Male|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|249|210393524|Male|Hemangioma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|210393524|Male|Hemangioma|2008-2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|48|42550225|Male|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41999118|Male|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|41821254|Male|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41821254|Male|Hemangioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Local Extensions from Regional Tumors|2008-2012|~|~|~
0-19|~|~|~|Malignant|~|210393524|Male|Local Extensions from Regional Tumors|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|38|210393524|Male|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|48|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|281|210393524|Male|Meningioma|2008-2012|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|20|210393524|Male|Meningioma|2008-2012|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|58|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42550225|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|41999118|Male|Meningioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|41821254|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41821254|Male|Meningioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Mixed glioma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|210393524|Male|Mixed glioma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42550225|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|Mixed glioma|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Neoplasm, unspecified|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|61|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|46|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|326|210393524|Male|Neoplasm, unspecified|2008-2012|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|100|210393524|Male|Neoplasm, unspecified|2008-2012|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|88|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|74|42550225|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42550225|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|65|41999118|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|41999118|Male|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|53|41821254|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|41821254|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|120|41889233|Male|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|630|210393524|Male|Nerve sheath, benign and malignant|2008-2012|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210393524|Male|Nerve sheath, benign and malignant|2008-2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|42550225|Male|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550225|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|41999118|Male|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41999118|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|41821254|Male|Nerve sheath, benign and malignant|2012|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41821254|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Neuroepithelial|2008-2012|~|~|~
0-19|~|~|~|Malignant|~|210393524|Male|Neuroepithelial|2008-2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|41999118|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|41821254|Male|Neuroepithelial|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|157|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|157|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|169|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|168|42541971|Male|Neuronal/glial, neuronal|2008|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|861|210393524|Male|Neuronal/glial, neuronal|2008-2012|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|97|210393524|Male|Neuronal/glial, neuronal|2008-2012|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|158|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|16|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|167|42550225|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42550225|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|177|41999118|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|19|41999118|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|193|41821254|Male|Neuronal/glial, neuronal|2012|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|18|41821254|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|31|42541971|Male|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Oligodendroglioma|2008-2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|117|210393524|Male|Oligodendroglioma|2008-2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42550225|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41999118|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41821254|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|128|210393524|Male|Other mesenchymal|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|30|210393524|Male|Other mesenchymal|2008-2012|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|42550225|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41999118|Male|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41999118|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|41821254|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41821254|Male|Other mesenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|367|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|343|42006384|Male|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|358|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|341|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|384|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Pilocytic astrocytoma|2008-2012|~|~|~
0-19|0.9|0.9|0.9|Malignant|1866|210393524|Male|Pilocytic astrocytoma|2008-2012|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|359|42609915|Male|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|0.9|0.9|Malignant|363|42550225|Male|Pilocytic astrocytoma|2010|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|373|41999118|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|396|41821254|Male|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210393524|Male|Pineal parenchymal|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|80|210393524|Male|Pineal parenchymal|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550225|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42550225|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|41999118|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41999118|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41821254|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41821254|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|81|41889233|Male|Pituitary|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|88|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|124|42541971|Male|Pituitary|2008|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|676|210393524|Male|Pituitary|2008-2012|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210393524|Male|Pituitary|2008-2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|42609915|Male|Pituitary|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|122|42550225|Male|Pituitary|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550225|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|41999118|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41999118|Male|Pituitary|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|41821254|Male|Pituitary|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41821254|Male|Pituitary|2012|~|~|~
0-19|1.4|1.7|1.6|Benign/Borderline|656|41889233|Male|Total|2004|1.4|1.7|1.6
0-19|3.4|3.8|3.6|Malignant|1491|41889233|Male|Total|2004|3.4|3.7|3.6
0-19|1.7|1.9|1.8|Benign/Borderline|752|42006384|Male|Total|2005|1.7|1.9|1.8
0-19|3.2|3.6|3.4|Malignant|1409|42006384|Male|Total|2005|3.2|3.5|3.4
0-19|1.7|1.9|1.8|Benign/Borderline|767|42158997|Male|Total|2006|1.7|2.0|1.8
0-19|3.4|3.7|3.6|Malignant|1493|42158997|Male|Total|2006|3.4|3.7|3.5
0-19|1.8|2.0|1.9|Benign/Borderline|805|42367071|Male|Total|2007|1.8|2.0|1.9
0-19|3.4|3.7|3.6|Malignant|1503|42367071|Male|Total|2007|3.4|3.7|3.5
0-19|1.7|2.0|1.9|Benign/Borderline|795|42541971|Male|Total|2008|1.7|2.0|1.9
0-19|3.5|3.9|3.7|Malignant|1577|42541971|Male|Total|2008|3.5|3.9|3.7
0-19|1.9|2.1|2.0|Benign/Borderline|4235|210393524|Male|Total|2008-2012|2.0|2.1|2.0
0-19|3.6|3.7|3.7|Malignant|7683|210393524|Male|Total|2008-2012|3.6|3.7|3.7
0-19|1.9|2.2|2.1|Benign/Borderline|892|42609915|Male|Total|2009|2.0|2.2|2.1
0-19|3.4|3.8|3.6|Malignant|1531|42609915|Male|Total|2009|3.4|3.8|3.6
0-19|1.8|2.1|1.9|Benign/Borderline|820|42550225|Male|Total|2010|1.8|2.1|1.9
0-19|3.5|3.9|3.7|Malignant|1563|42550225|Male|Total|2010|3.5|3.9|3.7
0-19|1.9|2.1|2.0|Benign/Borderline|850|41999118|Male|Total|2011|1.9|2.2|2.0
0-19|3.4|3.8|3.6|Malignant|1507|41999118|Male|Total|2011|3.4|3.8|3.6
0-19|2.0|2.2|2.1|Benign/Borderline|881|41821254|Male|Total|2012|2.0|2.3|2.1
0-19|3.5|3.9|3.7|Malignant|1533|41821254|Male|Total|2012|3.5|3.9|3.7
0-19|0.2|0.3|0.3|Benign/Borderline|120|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|630|210393524|Male|Tumors of Cranial and Spinal Nerves|2008-2012|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|210393524|Male|Tumors of Cranial and Spinal Nerves|2008-2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|42550225|Male|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42550225|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|41999118|Male|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41999118|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|41821254|Male|Tumors of Cranial and Spinal Nerves|2012|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41821254|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|225|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.2|Malignant|1352|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|255|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.2|3.1|Malignant|1278|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|257|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1343|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|261|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1356|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|265|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1414|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.5|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|1367|210393524|Male|Tumors of Neuroepthelial Tissue|2008-2012|0.6|0.7|0.6
0-19|3.2|3.4|3.3|Malignant|6928|210393524|Male|Tumors of Neuroepthelial Tissue|2008-2012|3.2|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|264|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1388|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.4|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|270|42550225|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1406|42550225|Male|Tumors of Neuroepthelial Tissue|2010|3.1|3.5|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|279|41999118|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.7
0-19|3.1|3.5|3.3|Malignant|1376|41999118|Male|Tumors of Neuroepthelial Tissue|2011|3.1|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|291|41821254|Male|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.1|3.5|3.3|Malignant|1369|41821254|Male|Tumors of Neuroepthelial Tissue|2012|3.1|3.5|3.3
0-19|0.3|0.5|0.4|Benign/Borderline|164|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|203|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|164|42158997|Male|Tumors of Sellar Region|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|199|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|217|42541971|Male|Tumors of Sellar Region|2008|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.5|0.5|Benign/Borderline|1072|210393524|Male|Tumors of Sellar Region|2008-2012|0.5|0.5|0.5
0-19|~|~|~|Malignant|~|210393524|Male|Tumors of Sellar Region|2008-2012|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|227|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|202|42550225|Male|Tumors of Sellar Region|2010|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42550225|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|203|41999118|Male|Tumors of Sellar Region|2011|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|41999118|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|223|41821254|Male|Tumors of Sellar Region|2012|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|41821254|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42006384|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42541971|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|493|210393524|Male|Tumors of the Meninges|2008-2012|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|50|210393524|Male|Tumors of the Meninges|2008-2012|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|92|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42550225|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42550225|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|41999118|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41999118|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|41821254|Male|Tumors of the Meninges|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41821254|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unclassified Tumors|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|107|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|27|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|78|42541971|Male|Unclassified Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|576|210393524|Male|Unclassified Tumors|2008-2012|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|109|210393524|Male|Unclassified Tumors|2008-2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|143|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|123|42550225|Male|Unclassified Tumors|2010|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|42550225|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|123|41999118|Male|Unclassified Tumors|2011|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|41999118|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|109|41821254|Male|Unclassified Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|29|41821254|Male|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|155|210393524|Male|Unique astrocytoma variants|2008-2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|104|210393524|Male|Unique astrocytoma variants|2008-2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|42550225|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550225|Male|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|41999118|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|41999118|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|28|41821254|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|41821254|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|36|411224220|Male and Female|All other|2008-2012|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|53|411224220|Male and Female|All other|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|83180117|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82089424|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|81757252|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|69|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|65|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Anaplastic astrocytoma|2008-2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|364|411224220|Male and Female|Anaplastic astrocytoma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|82|83180117|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82089424|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|81757252|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Anaplastic oligodendroglioma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|30|411224220|Male and Female|Anaplastic oligodendroglioma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83180117|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82089424|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|81757252|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|190|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|181|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Astrocytoma, NOS|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|926|411224220|Male and Female|Astrocytoma, NOS|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83180117|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|178|82089424|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|158|81757252|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|53|82005260|Male and Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|78|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|319|411224220|Male and Female|Choroid plexus|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|90|411224220|Male and Female|Choroid plexus|2008-2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|66|83180117|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|83180117|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|58|82089424|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82089424|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|58|81757252|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|81757252|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|163|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|163|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|151|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|179|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|155|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|794|411224220|Male and Female|Craniopharyngioma|2008-2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|411224220|Male and Female|Craniopharyngioma|2008-2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|169|83180117|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83180117|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|148|82089424|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82089424|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|151|81757252|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81757252|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|40|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Diffuse astrocytoma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|169|411224220|Male and Female|Diffuse astrocytoma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|83180117|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82089424|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|81757252|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|496|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|518|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|549|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
0-19|0.6|0.6|0.6|Malignant|2486|411224220|Male and Female|Embryonal/primitive/medulloblastoma|2008-2012|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|511|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|488|83180117|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|488|82089424|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|462|81757252|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|170|411224220|Male and Female|Ependymoma variants|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411224220|Male and Female|Ependymoma variants|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83180117|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83180117|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82089424|Male and Female|Ependymoma variants|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82089424|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|81757252|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81757252|Male and Female|Ependymoma variants|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|208|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|173|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Ependymoma/anaplastic ependymoma|2008-2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|975|411224220|Male and Female|Ependymoma/anaplastic ependymoma|2008-2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|83180117|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82089424|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|81757252|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|30|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|147|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|34|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|144|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|181|411224220|Male and Female|Germ Cell Tumors|2008-2012|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|706|411224220|Male and Female|Germ Cell Tumors|2008-2012|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|45|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|137|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|83180117|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|164|83180117|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|33|82089424|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|134|82089424|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|29|81757252|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|128|81757252|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|126|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|110|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|126|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Glioblastoma|2008-2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|660|411224220|Male and Female|Glioblastoma|2008-2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83180117|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|153|82089424|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|144|81757252|Male and Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|459|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|447|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.6|0.6|Malignant|480|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|501|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|534|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|115|411224220|Male and Female|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|2596|411224220|Male and Female|Glioma malignant, NOS|2008-2012|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|553|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|22|83180117|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|510|83180117|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|35|82089424|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|539|82089424|Male and Female|Glioma malignant, NOS|2011|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|38|81757252|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|461|81757252|Male and Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|143|411224220|Male and Female|Hemangioblastoma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411224220|Male and Female|Hemangioblastoma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|83180117|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83180117|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82089424|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82089424|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|81757252|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81757252|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|42|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|62|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|70|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|70|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|497|411224220|Male and Female|Hemangioma|2008-2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|411224220|Male and Female|Hemangioma|2008-2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|103|83280391|Male and Female|Hemangioma|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|83180117|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83180117|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|118|82089424|Male and Female|Hemangioma|2011|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82089424|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|81757252|Male and Female|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81757252|Male and Female|Hemangioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Local Extensions from Regional Tumors|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|411224220|Male and Female|Local Extensions from Regional Tumors|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83180117|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82089424|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|81757252|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|66|411224220|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83180117|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82089424|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|81757252|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|90|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|124|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|97|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|101|82749431|Male and Female|Meningioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|113|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|581|411224220|Male and Female|Meningioma|2008-2012|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|29|411224220|Male and Female|Meningioma|2008-2012|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|116|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|83180117|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83180117|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|126|82089424|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82089424|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|117|81757252|Male and Female|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81757252|Male and Female|Meningioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Mixed glioma|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|139|411224220|Male and Female|Mixed glioma|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83180117|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82089424|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|81757252|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|58|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|41|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|107|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|35|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|98|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|39|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|121|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|668|411224220|Male and Female|Neoplasm, unspecified|2008-2012|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|186|411224220|Male and Female|Neoplasm, unspecified|2008-2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|145|83280391|Male and Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|160|83180117|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83180117|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|129|82089424|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|82089424|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|114|81757252|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|48|81757252|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|227|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|269|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|300|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|264|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|256|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1212|411224220|Male and Female|Nerve sheath, benign and malignant|2008-2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|411224220|Male and Female|Nerve sheath, benign and malignant|2008-2012|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|273|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|229|83180117|Male and Female|Nerve sheath, benign and malignant|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83180117|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|227|82089424|Male and Female|Nerve sheath, benign and malignant|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82089424|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|228|81757252|Male and Female|Nerve sheath, benign and malignant|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81757252|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Neuroepithelial|2008-2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|43|411224220|Male and Female|Neuroepithelial|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83180117|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82089424|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|81757252|Male and Female|Neuroepithelial|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|261|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|292|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|278|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|305|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|61|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|298|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|55|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|1551|411224220|Male and Female|Neuronal/glial, neuronal|2008-2012|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|189|411224220|Male and Female|Neuronal/glial, neuronal|2008-2012|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|290|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|32|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|309|83180117|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83180117|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|82089424|Male and Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|33|82089424|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|339|81757252|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|35|81757252|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|51|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Oligodendroglioma|2008-2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|213|411224220|Male and Female|Oligodendroglioma|2008-2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|42|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83180117|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82089424|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|45|81757252|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82749431|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|261|411224220|Male and Female|Other mesenchymal|2008-2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|62|411224220|Male and Female|Other mesenchymal|2008-2012|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|46|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|45|83180117|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83180117|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|53|82089424|Male and Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82089424|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|83|81757252|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81757252|Male and Female|Other mesenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|695|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|658|82005260|Male and Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|668|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|671|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|709|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|411224220|Male and Female|Pilocytic astrocytoma|2008-2012|~|~|~
0-19|0.8|0.9|0.9|Malignant|3584|411224220|Male and Female|Pilocytic astrocytoma|2008-2012|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.8|Malignant|699|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|734|83180117|Male and Female|Pilocytic astrocytoma|2010|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|0.9|0.9|Malignant|712|82089424|Male and Female|Pilocytic astrocytoma|2011|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|746|81757252|Male and Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|38|411224220|Male and Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|152|411224220|Male and Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83180117|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|83180117|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82089424|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82089424|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81757252|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|81757252|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|326|81754354|Male and Female|Pituitary|2004|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|403|82005260|Male and Female|Pituitary|2005|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|406|82324418|Male and Female|Pituitary|2006|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|420|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|468|83118264|Male and Female|Pituitary|2008|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.6|0.6|Benign/Borderline|2485|411224220|Male and Female|Pituitary|2008-2012|0.6|0.6|0.6
0-19|~|~|~|Malignant|~|411224220|Male and Female|Pituitary|2008-2012|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|489|83280391|Male and Female|Pituitary|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|513|83180117|Male and Female|Pituitary|2010|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83180117|Male and Female|Pituitary|2010|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|503|82089424|Male and Female|Pituitary|2011|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|82089424|Male and Female|Pituitary|2011|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|517|81757252|Male and Female|Pituitary|2012|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81757252|Male and Female|Pituitary|2012|~|~|~
0-19|1.6|1.8|1.7|Benign/Borderline|1398|81754354|Male and Female|Total|2004|1.6|1.8|1.7
0-19|3.3|3.5|3.4|Malignant|2786|81754354|Male and Female|Total|2004|3.3|3.5|3.4
0-19|1.9|2.1|2.0|Benign/Borderline|1652|82005260|Male and Female|Total|2005|1.9|2.1|2.0
0-19|3.1|3.3|3.2|Malignant|2628|82005260|Male and Female|Total|2005|3.1|3.3|3.2
0-19|1.9|2.1|2.0|Benign/Borderline|1668|82324418|Male and Female|Total|2006|1.9|2.1|2.0
0-19|3.2|3.4|3.3|Malignant|2707|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1723|82749431|Male and Female|Total|2007|2.0|2.2|2.1
0-19|3.3|3.5|3.4|Malignant|2789|82749431|Male and Female|Total|2007|3.2|3.5|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1759|83118264|Male and Female|Total|2008|2.0|2.2|2.1
0-19|3.3|3.6|3.4|Malignant|2845|83118264|Male and Female|Total|2008|3.3|3.6|3.4
0-19|2.2|2.3|2.2|Benign/Borderline|9300|411224220|Male and Female|Total|2008-2012|2.2|2.3|2.3
0-19|3.3|3.4|3.4|Malignant|13917|411224220|Male and Female|Total|2008-2012|3.3|3.4|3.4
0-19|2.1|2.3|2.2|Benign/Borderline|1883|83280391|Male and Female|Total|2009|2.2|2.4|2.3
0-19|3.2|3.5|3.4|Malignant|2797|83280391|Male and Female|Total|2009|3.2|3.5|3.4
0-19|2.1|2.3|2.2|Benign/Borderline|1873|83180117|Male and Female|Total|2010|2.2|2.4|2.3
0-19|3.3|3.5|3.4|Malignant|2824|83180117|Male and Female|Total|2010|3.3|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1880|82089424|Male and Female|Total|2011|2.2|2.4|2.3
0-19|3.3|3.5|3.4|Malignant|2804|82089424|Male and Female|Total|2011|3.3|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1916|81757252|Male and Female|Total|2012|2.2|2.5|2.3
0-19|3.2|3.4|3.3|Malignant|2699|81757252|Male and Female|Total|2012|3.2|3.4|3.3
0-19|0.2|0.3|0.3|Benign/Borderline|227|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|269|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|300|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|264|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|256|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1213|411224220|Male and Female|Tumors of Cranial and Spinal Nerves|2008-2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|411224220|Male and Female|Tumors of Cranial and Spinal Nerves|2008-2012|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|273|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|229|83180117|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|83180117|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|228|82089424|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82089424|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|228|81757252|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|81757252|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|411|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.1|Malignant|2550|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.2|3.1
0-19|0.5|0.6|0.5|Benign/Borderline|445|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
0-19|2.8|3.1|3.0|Malignant|2407|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.8|3.1|2.9
0-19|0.5|0.6|0.5|Benign/Borderline|455|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|2490|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|486|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.3|3.1|Malignant|2577|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|482|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|3.1|3.3|3.2|Malignant|2627|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.0|3.3|3.2
0-19|0.6|0.6|0.6|Benign/Borderline|2473|411224220|Male and Female|Tumors of Neuroepthelial Tissue|2008-2012|0.6|0.6|0.6
0-19|3.1|3.2|3.1|Malignant|12807|411224220|Male and Female|Tumors of Neuroepthelial Tissue|2008-2012|3.1|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|467|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2574|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|492|83180117|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2586|83180117|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|507|82089424|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|2593|82089424|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|528|81757252|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|2475|81757252|Male and Female|Tumors of Neuroepthelial Tissue|2012|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|489|81754354|Male and Female|Tumors of Sellar Region|2004|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|566|82005260|Male and Female|Tumors of Sellar Region|2005|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|557|82324418|Male and Female|Tumors of Sellar Region|2006|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|599|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|623|83118264|Male and Female|Tumors of Sellar Region|2008|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.8|0.8|Benign/Borderline|3279|411224220|Male and Female|Tumors of Sellar Region|2008-2012|0.8|0.8|0.8
0-19|~|~|~|Malignant|~|411224220|Male and Female|Tumors of Sellar Region|2008-2012|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|660|83280391|Male and Female|Tumors of Sellar Region|2009|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|682|83180117|Male and Female|Tumors of Sellar Region|2010|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83180117|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|651|82089424|Male and Female|Tumors of Sellar Region|2011|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|82089424|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|668|81757252|Male and Female|Tumors of Sellar Region|2012|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|81757252|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|144|81754354|Male and Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|19|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|189|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|153|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|165|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|985|411224220|Male and Female|Tumors of the Meninges|2008-2012|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|92|411224220|Male and Female|Tumors of the Meninges|2008-2012|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|190|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|179|83180117|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|83180117|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|214|82089424|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82089424|Male and Female|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|234|81757252|Male and Female|Tumors of the Meninges|2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|20|81757252|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|96|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|41|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|149|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|160|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|178|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|44|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|191|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|38|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1166|411224220|Male and Female|Unclassified Tumors|2008-2012|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|198|411224220|Male and Female|Unclassified Tumors|2008-2012|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|248|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|41|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|83180117|Male and Female|Unclassified Tumors|2010|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|30|83180117|Male and Female|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|247|82089424|Male and Female|Unclassified Tumors|2011|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|39|82089424|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|229|81757252|Male and Female|Unclassified Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|51|81757252|Male and Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|48|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|48|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|55|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|58|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|267|411224220|Male and Female|Unique astrocytoma variants|2008-2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|185|411224220|Male and Female|Unique astrocytoma variants|2008-2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|67|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|45|83180117|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|83180117|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|44|82089424|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|46|82089424|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|53|81757252|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81757252|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|77|578005607|Female|All other|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|48|578005607|Female|All other|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|116608556|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|116608556|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116883797|Female|All other|2011|~|~|~
20+|~|~|~|Malignant|~|116883797|Female|All other|2011|~|~|~
20+|~|~|~|Benign/Borderline|~|118096283|Female|All other|2012|~|~|~
20+|~|~|~|Malignant|~|118096283|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|513|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|509|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|531|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|496|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|578005607|Female|Anaplastic astrocytoma|2008-2012|~|~|~
20+|0.4|0.5|0.4|Malignant|2664|578005607|Female|Anaplastic astrocytoma|2008-2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|498|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116608556|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|561|116608556|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|116883797|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|555|116883797|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|118096283|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|565|118096283|Female|Anaplastic astrocytoma|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|181|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|138|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|152|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|167|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|578005607|Female|Anaplastic oligodendroglioma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|738|578005607|Female|Anaplastic oligodendroglioma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|141|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116608556|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|128|116608556|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116883797|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|143|116883797|Female|Anaplastic oligodendroglioma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118096283|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|161|118096283|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|572|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|558|110320645|Female|Astrocytoma, NOS|2005|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|534|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|528|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|487|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|578005607|Female|Astrocytoma, NOS|2008-2012|~|~|~
20+|0.4|0.4|0.4|Malignant|2345|578005607|Female|Astrocytoma, NOS|2008-2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|481|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116608556|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|466|116608556|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116883797|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|446|116883797|Female|Astrocytoma, NOS|2011|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|118096283|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|473|118096283|Female|Astrocytoma, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|38|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|41|111567226|Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|222|578005607|Female|Choroid plexus|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|578005607|Female|Choroid plexus|2008-2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|116608556|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116608556|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|116883797|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116883797|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|118096283|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118096283|Female|Choroid plexus|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|193|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1082|578005607|Female|Craniopharyngioma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|578005607|Female|Craniopharyngioma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|116608556|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116608556|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|210|116883797|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116883797|Female|Craniopharyngioma|2011|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|203|118096283|Female|Craniopharyngioma|2012|0.1|0.2|0.2
20+|~|~|~|Malignant|~|118096283|Female|Craniopharyngioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|131|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|135|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|578005607|Female|Diffuse astrocytoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|660|578005607|Female|Diffuse astrocytoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|163|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116608556|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|161|116608556|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116883797|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|111|116883797|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118096283|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|91|118096283|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|84|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|90|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|87|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|578005607|Female|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|413|578005607|Female|Embryonal/primitive/medulloblastoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|105|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116608556|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|74|116608556|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116883797|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|67|116883797|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118096283|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|82|118096283|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|109|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|576|578005607|Female|Ependymoma variants|2008-2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|578005607|Female|Ependymoma variants|2008-2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|116608556|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116608556|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|115|116883797|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116883797|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|123|118096283|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|118096283|Female|Ependymoma variants|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|292|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|300|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|291|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|293|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|310|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|32|578005607|Female|Ependymoma/anaplastic ependymoma|2008-2012|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1513|578005607|Female|Ependymoma/anaplastic ependymoma|2008-2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|335|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116608556|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|292|116608556|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116883797|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|293|116883797|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118096283|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.2|Malignant|293|118096283|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|156|578005607|Female|Germ Cell Tumors|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|578005607|Female|Germ Cell Tumors|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|37|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|116608556|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116608556|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116883797|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116883797|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|118096283|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118096283|Female|Germ Cell Tumors|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4087|109112165|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4148|110320645|Female|Glioblastoma|2005|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.4|3.7|3.5|Malignant|4278|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4364|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4397|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|578005607|Female|Glioblastoma|2008-2012|~|~|~
20+|3.5|3.5|3.5|Malignant|22648|578005607|Female|Glioblastoma|2008-2012|3.9|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4452|115293599|Female|Glioblastoma|2009|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116608556|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4586|116608556|Female|Glioblastoma|2010|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116883797|Female|Glioblastoma|2011|~|~|~
20+|3.3|3.5|3.4|Malignant|4532|116883797|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|118096283|Female|Glioblastoma|2012|~|~|~
20+|3.4|3.6|3.5|Malignant|4762|118096283|Female|Glioblastoma|2012|3.9|4.1|4.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|420|109112165|Female|Glioma malignant, NOS|2004|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|386|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|390|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|403|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|431|114027722|Female|Glioma malignant, NOS|2008|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|44|578005607|Female|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|2148|578005607|Female|Glioma malignant, NOS|2008-2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|509|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116608556|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|396|116608556|Female|Glioma malignant, NOS|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116883797|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|421|116883797|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|118096283|Female|Glioma malignant, NOS|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|400|118096283|Female|Glioma malignant, NOS|2012|0.3|0.4|0.3
20+|0.2|0.2|0.2|Benign/Borderline|202|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|210|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|233|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1149|578005607|Female|Hemangioblastoma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|578005607|Female|Hemangioblastoma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|116608556|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116608556|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|116883797|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116883797|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|242|118096283|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118096283|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|272|110320645|Female|Hemangioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|305|111567226|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|355|112783993|Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|442|114027722|Female|Hemangioma|2008|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|2846|578005607|Female|Hemangioma|2008-2012|0.5|0.5|0.5
20+|~|~|~|Malignant|~|578005607|Female|Hemangioma|2008-2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|486|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|619|116608556|Female|Hemangioma|2010|0.5|0.6|0.5
20+|~|~|~|Malignant|~|116608556|Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|667|116883797|Female|Hemangioma|2011|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116883797|Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|634|118096283|Female|Hemangioma|2012|0.5|0.6|0.5
20+|~|~|~|Malignant|~|118096283|Female|Hemangioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|578005607|Female|Local Extensions from Regional Tumors|2008-2012|~|~|~
20+|0.0|0.0|0.0|Malignant|109|578005607|Female|Local Extensions from Regional Tumors|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116608556|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|22|116608556|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116883797|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|116883797|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118096283|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|19|118096283|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|594|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|659|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|671|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|635|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|699|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|578005607|Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
20+|0.5|0.6|0.6|Malignant|3494|578005607|Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|662|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116608556|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|749|116608556|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|116883797|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|711|116883797|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|118096283|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|688|118096283|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|11.6|12.0|11.8|Benign/Borderline|13695|109112165|Female|Meningioma|2004|12.3|12.8|12.6
20+|0.2|0.3|0.2|Malignant|274|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.0|13.4|13.2|Benign/Borderline|15646|110320645|Female|Meningioma|2005|14.0|14.4|14.2
20+|0.2|0.3|0.2|Malignant|276|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|13.6|14.0|13.8|Benign/Borderline|16598|111567226|Female|Meningioma|2006|14.7|15.1|14.9
20+|0.2|0.2|0.2|Malignant|256|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|13.9|14.4|14.1|Benign/Borderline|17303|112783993|Female|Meningioma|2007|15.1|15.6|15.3
20+|0.2|0.2|0.2|Malignant|268|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|14.5|15.0|14.7|Benign/Borderline|18372|114027722|Female|Meningioma|2008|15.9|16.3|16.1
20+|0.1|0.2|0.2|Malignant|214|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|14.7|14.9|14.8|Benign/Borderline|94729|578005607|Female|Meningioma|2008-2012|16.3|16.5|16.4
20+|0.1|0.2|0.2|Malignant|974|578005607|Female|Meningioma|2008-2012|0.2|0.2|0.2
20+|15.3|15.8|15.6|Benign/Borderline|19704|115293599|Female|Meningioma|2009|16.9|17.3|17.1
20+|0.1|0.2|0.2|Malignant|200|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|14.6|15.0|14.8|Benign/Borderline|19015|116608556|Female|Meningioma|2010|16.1|16.5|16.3
20+|0.1|0.2|0.2|Malignant|199|116608556|Female|Meningioma|2010|0.1|0.2|0.2
20+|14.5|14.9|14.7|Benign/Borderline|19020|116883797|Female|Meningioma|2011|16.0|16.5|16.3
20+|0.1|0.2|0.1|Malignant|177|116883797|Female|Meningioma|2011|0.1|0.2|0.2
20+|14.2|14.6|14.4|Benign/Borderline|18970|118096283|Female|Meningioma|2012|15.8|16.3|16.1
20+|0.1|0.2|0.1|Malignant|187|118096283|Female|Meningioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|194|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|238|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|270|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|237|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|261|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|578005607|Female|Mixed glioma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Malignant|1298|578005607|Female|Mixed glioma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.2|Malignant|278|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116608556|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|266|116608556|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116883797|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|265|116883797|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|118096283|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|232|118096283|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|0.5|0.6|0.6|Benign/Borderline|679|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|702|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|861|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|729|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|776|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.5|0.6|0.6|Malignant|727|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|811|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|655|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|812|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|755|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|4022|578005607|Female|Neoplasm, unspecified|2008-2012|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|3392|578005607|Female|Neoplasm, unspecified|2008-2012|0.6|0.6|0.6
20+|0.7|0.8|0.7|Benign/Borderline|893|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|784|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|791|116608556|Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|637|116608556|Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|772|116883797|Female|Neoplasm, unspecified|2011|0.6|0.7|0.7
20+|0.4|0.5|0.4|Malignant|624|116883797|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|773|118096283|Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.4|0.5|0.4|Malignant|609|118096283|Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2487|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2733|110320645|Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2853|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2832|112783993|Female|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2907|114027722|Female|Nerve sheath, benign and malignant|2008|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.4|2.4|2.4|Benign/Borderline|14598|578005607|Female|Nerve sheath, benign and malignant|2008-2012|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|107|578005607|Female|Nerve sheath, benign and malignant|2008-2012|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3037|115293599|Female|Nerve sheath, benign and malignant|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|2777|116608556|Female|Nerve sheath, benign and malignant|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|116608556|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2920|116883797|Female|Nerve sheath, benign and malignant|2011|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|19|116883797|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2994|118096283|Female|Nerve sheath, benign and malignant|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|118096283|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|578005607|Female|Neuroepithelial|2008-2012|~|~|~
20+|0.0|0.0|0.0|Malignant|121|578005607|Female|Neuroepithelial|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116608556|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116608556|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116883797|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|116883797|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118096283|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|26|118096283|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|153|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|181|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|198|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1085|578005607|Female|Neuronal/glial, neuronal|2008-2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|101|578005607|Female|Neuronal/glial, neuronal|2008-2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|243|116608556|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|116608556|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|231|116883797|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|116883797|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|197|118096283|Female|Neuronal/glial, neuronal|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|118096283|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|349|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|351|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|372|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|364|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|351|114027722|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|578005607|Female|Oligodendroglioma|2008-2012|~|~|~
20+|0.3|0.3|0.3|Malignant|1603|578005607|Female|Oligodendroglioma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|351|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116608556|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|324|116608556|Female|Oligodendroglioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116883797|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|301|116883797|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118096283|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|282|118096283|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|66|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|84|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|50|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|463|578005607|Female|Other mesenchymal|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|168|578005607|Female|Other mesenchymal|2008-2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|116608556|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|116608556|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|116883797|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|116883797|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|118096283|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|118096283|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|122|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|148|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|160|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|578005607|Female|Pilocytic astrocytoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|707|578005607|Female|Pilocytic astrocytoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|133|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116608556|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|163|116608556|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116883797|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|156|116883797|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|118096283|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|116|118096283|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|183|578005607|Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|115|578005607|Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|116608556|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|116608556|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|40|116883797|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|116883797|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|118096283|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|118096283|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|3.4|3.7|3.5|Benign/Borderline|3851|109112165|Female|Pituitary|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|3.9|4.2|4.1|Benign/Borderline|4456|110320645|Female|Pituitary|2005|3.9|4.2|4.0
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4953|111567226|Female|Pituitary|2006|4.3|4.6|4.4
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.4|4.6|4.5|Benign/Borderline|5041|112783993|Female|Pituitary|2007|4.3|4.6|4.5
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|4.6|4.9|4.7|Benign/Borderline|5353|114027722|Female|Pituitary|2008|4.6|4.8|4.7
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|28521|578005607|Female|Pituitary|2008-2012|4.9|5.0|4.9
20+|0.0|0.0|0.0|Malignant|55|578005607|Female|Pituitary|2008-2012|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|5927|115293599|Female|Pituitary|2009|5.0|5.3|5.1
20+|~|~|~|Malignant|~|115293599|Female|Pituitary|2009|~|~|~
20+|4.8|5.1|5.0|Benign/Borderline|5737|116608556|Female|Pituitary|2010|4.8|5.0|4.9
20+|~|~|~|Malignant|~|116608556|Female|Pituitary|2010|~|~|~
20+|4.9|5.1|5.0|Benign/Borderline|5745|116883797|Female|Pituitary|2011|4.8|5.0|4.9
20+|~|~|~|Malignant|~|116883797|Female|Pituitary|2011|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5840|118096283|Female|Pituitary|2012|4.8|5.1|4.9
20+|~|~|~|Malignant|~|118096283|Female|Pituitary|2012|~|~|~
20+|18.8|19.4|19.1|Benign/Borderline|21795|109112165|Female|Total|2004|19.7|20.2|20.0
20+|7.4|7.8|7.6|Malignant|8718|109112165|Female|Total|2004|7.8|8.2|8.0
20+|21.3|21.8|21.5|Benign/Borderline|24930|110320645|Female|Total|2005|22.3|22.9|22.6
20+|7.5|7.8|7.6|Malignant|8881|110320645|Female|Total|2005|7.9|8.2|8.1
20+|22.3|22.8|22.5|Benign/Borderline|26495|111567226|Female|Total|2006|23.5|24.0|23.7
20+|7.4|7.7|7.6|Malignant|8942|111567226|Female|Total|2006|7.8|8.2|8.0
20+|22.7|23.2|22.9|Benign/Borderline|27362|112783993|Female|Total|2007|24.0|24.5|24.3
20+|7.4|7.7|7.5|Malignant|9019|112783993|Female|Total|2007|7.8|8.2|8.0
20+|23.6|24.2|23.9|Benign/Borderline|28960|114027722|Female|Total|2008|25.1|25.7|25.4
20+|7.4|7.7|7.5|Malignant|9165|114027722|Female|Total|2008|7.9|8.2|8.0
20+|24.2|24.4|24.3|Benign/Borderline|150122|578005607|Female|Total|2008-2012|25.8|26.1|26.0
20+|7.2|7.4|7.3|Malignant|45622|578005607|Female|Total|2008-2012|7.8|8.0|7.9
20+|25.0|25.6|25.3|Benign/Borderline|31128|115293599|Female|Total|2009|26.7|27.3|27.0
20+|7.3|7.6|7.5|Malignant|9293|115293599|Female|Total|2009|7.9|8.2|8.1
20+|23.8|24.4|24.1|Benign/Borderline|30043|116608556|Female|Total|2010|25.5|26.1|25.8
20+|7.1|7.4|7.3|Malignant|9200|116608556|Female|Total|2010|7.7|8.1|7.9
20+|23.9|24.5|24.2|Benign/Borderline|30219|116883797|Female|Total|2011|25.6|26.1|25.9
20+|6.9|7.2|7.1|Malignant|8989|116883797|Female|Total|2011|7.5|7.9|7.7
20+|23.5|24.1|23.8|Benign/Borderline|30278|118096283|Female|Total|2012|25.4|25.9|25.6
20+|6.9|7.2|7.1|Malignant|9150|118096283|Female|Total|2012|7.6|7.9|7.7
20+|2.1|2.3|2.2|Benign/Borderline|2487|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|20|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2736|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2854|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2833|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2909|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|25|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.4|2.4|2.4|Benign/Borderline|14608|578005607|Female|Tumors of Cranial and Spinal Nerves|2008-2012|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|107|578005607|Female|Tumors of Cranial and Spinal Nerves|2008-2012|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3040|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.2|2.3|2.3|Benign/Borderline|2780|116608556|Female|Tumors of Cranial and Spinal Nerves|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|22|116608556|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2922|116883797|Female|Tumors of Cranial and Spinal Nerves|2011|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|19|116883797|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2994|118096283|Female|Tumors of Cranial and Spinal Nerves|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|118096283|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Benign/Borderline|374|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.0|6.3|6.2|Malignant|7035|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.4
20+|0.4|0.4|0.4|Benign/Borderline|434|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7106|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|469|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7186|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.4
20+|0.4|0.5|0.4|Benign/Borderline|470|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7343|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|478|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.2|6.1|Malignant|7367|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|2524|578005607|Female|Tumors of Neuroepthelial Tissue|2008-2012|0.4|0.5|0.4
20+|5.9|6.1|6.0|Malignant|37232|578005607|Female|Tumors of Neuroepthelial Tissue|2008-2012|6.4|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|497|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7550|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|528|116608556|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.1|6.0|Malignant|7508|116608556|Female|Tumors of Neuroepthelial Tissue|2010|6.3|6.6|6.4
20+|0.4|0.5|0.5|Benign/Borderline|533|116883797|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.7|6.0|5.9|Malignant|7383|116883797|Female|Tumors of Neuroepthelial Tissue|2011|6.2|6.5|6.3
20+|0.4|0.5|0.4|Benign/Borderline|496|118096283|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.4
20+|5.8|6.0|5.9|Malignant|7564|118096283|Female|Tumors of Neuroepthelial Tissue|2012|6.3|6.6|6.4
20+|3.6|3.8|3.7|Benign/Borderline|4044|109112165|Female|Tumors of Sellar Region|2004|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|4638|110320645|Female|Tumors of Sellar Region|2005|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|5151|111567226|Female|Tumors of Sellar Region|2006|4.5|4.7|4.6
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|5257|112783993|Female|Tumors of Sellar Region|2007|4.5|4.8|4.7
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5573|114027722|Female|Tumors of Sellar Region|2008|4.8|5.0|4.9
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.1|5.2|5.2|Benign/Borderline|29603|578005607|Female|Tumors of Sellar Region|2008-2012|5.1|5.2|5.1
20+|0.0|0.0|0.0|Malignant|59|578005607|Female|Tumors of Sellar Region|2008-2012|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6152|115293599|Female|Tumors of Sellar Region|2009|5.2|5.5|5.3
20+|~|~|~|Malignant|~|115293599|Female|Tumors of Sellar Region|2009|~|~|~
20+|5.0|5.3|5.2|Benign/Borderline|5965|116608556|Female|Tumors of Sellar Region|2010|5.0|5.2|5.1
20+|~|~|~|Malignant|~|116608556|Female|Tumors of Sellar Region|2010|~|~|~
20+|5.0|5.3|5.2|Benign/Borderline|5955|116883797|Female|Tumors of Sellar Region|2011|5.0|5.2|5.1
20+|~|~|~|Malignant|~|116883797|Female|Tumors of Sellar Region|2011|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|6043|118096283|Female|Tumors of Sellar Region|2012|5.0|5.2|5.1
20+|~|~|~|Malignant|~|118096283|Female|Tumors of Sellar Region|2012|~|~|~
20+|11.8|12.2|12.0|Benign/Borderline|13963|109112165|Female|Tumors of the Meninges|2004|12.6|13.0|12.8
20+|0.2|0.3|0.3|Malignant|299|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.3|13.7|13.5|Benign/Borderline|15950|110320645|Female|Tumors of the Meninges|2005|14.2|14.7|14.5
20+|0.2|0.3|0.3|Malignant|303|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|13.8|14.3|14.1|Benign/Borderline|16898|111567226|Female|Tumors of the Meninges|2006|14.9|15.4|15.1
20+|0.2|0.3|0.2|Malignant|286|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.2|14.6|14.4|Benign/Borderline|17596|112783993|Female|Tumors of the Meninges|2007|15.4|15.8|15.6
20+|0.2|0.3|0.2|Malignant|305|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|14.8|15.3|15.0|Benign/Borderline|18708|114027722|Female|Tumors of the Meninges|2008|16.2|16.6|16.4
20+|0.2|0.2|0.2|Malignant|264|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|15.0|15.2|15.1|Benign/Borderline|96341|578005607|Female|Tumors of the Meninges|2008-2012|16.6|16.8|16.7
20+|0.2|0.2|0.2|Malignant|1144|578005607|Female|Tumors of the Meninges|2008-2012|0.2|0.2|0.2
20+|15.6|16.0|15.8|Benign/Borderline|20020|115293599|Female|Tumors of the Meninges|2009|17.1|17.6|17.4
20+|0.2|0.2|0.2|Malignant|225|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|14.8|15.3|15.0|Benign/Borderline|19327|116608556|Female|Tumors of the Meninges|2010|16.3|16.8|16.6
20+|0.2|0.2|0.2|Malignant|232|116608556|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|14.8|15.2|15.0|Benign/Borderline|19334|116883797|Female|Tumors of the Meninges|2011|16.3|16.8|16.5
20+|0.1|0.2|0.2|Malignant|206|116883797|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|14.5|14.9|14.7|Benign/Borderline|19307|118096283|Female|Tumors of the Meninges|2012|16.1|16.6|16.3
20+|0.1|0.2|0.2|Malignant|220|118096283|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|909|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|708|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1136|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|735|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1089|111567226|Female|Unclassified Tumors|2006|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|732|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1170|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|658|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1260|114027722|Female|Unclassified Tumors|2008|1.0|1.2|1.1
20+|0.5|0.6|0.6|Malignant|769|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.1|1.1|Benign/Borderline|6882|578005607|Female|Unclassified Tumors|2008-2012|1.2|1.2|1.2
20+|0.5|0.5|0.5|Malignant|3432|578005607|Female|Unclassified Tumors|2008-2012|0.6|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1380|115293599|Female|Unclassified Tumors|2009|1.1|1.3|1.2
20+|0.5|0.6|0.6|Malignant|792|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.2|1.1|Benign/Borderline|1413|116608556|Female|Unclassified Tumors|2010|1.1|1.3|1.2
20+|0.4|0.5|0.5|Malignant|645|116608556|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1442|116883797|Female|Unclassified Tumors|2011|1.2|1.3|1.2
20+|0.4|0.5|0.4|Malignant|629|116883797|Female|Unclassified Tumors|2011|0.5|0.6|0.5
20+|1.1|1.2|1.1|Benign/Borderline|1408|118096283|Female|Unclassified Tumors|2012|1.1|1.3|1.2
20+|0.4|0.5|0.4|Malignant|614|118096283|Female|Unclassified Tumors|2012|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|52|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|60|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|55|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|356|578005607|Female|Unique astrocytoma variants|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|126|578005607|Female|Unique astrocytoma variants|2008-2012|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|115293599|Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|64|116608556|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|116608556|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|76|116883797|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|116883797|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|118096283|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|118096283|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|104488268|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|67|542904382|Male|All other|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|542904382|Male|All other|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109537622|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109537622|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|109891392|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|109891392|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111265796|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|22|111265796|Male|All other|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|667|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|689|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|694|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|666|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|708|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|542904382|Male|Anaplastic astrocytoma|2008-2012|~|~|~
20+|0.6|0.7|0.7|Malignant|3525|542904382|Male|Anaplastic astrocytoma|2008-2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|704|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109537622|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|694|109537622|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|109891392|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|699|109891392|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|111265796|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|731|111265796|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|203|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|203|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|212|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|177|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|186|106947980|Male|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|542904382|Male|Anaplastic oligodendroglioma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Malignant|901|542904382|Male|Anaplastic oligodendroglioma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|182|108197539|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537622|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|185|109537622|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109891392|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|173|109891392|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111265796|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|178|111265796|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|634|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|628|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|646|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|622|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|621|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|542904382|Male|Astrocytoma, NOS|2008-2012|~|~|~
20+|0.5|0.6|0.5|Malignant|2884|542904382|Male|Astrocytoma, NOS|2008-2012|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|568|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109537622|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|601|109537622|Male|Astrocytoma, NOS|2010|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109891392|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|561|109891392|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111265796|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|540|111265796|Male|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|151|542904382|Male|Choroid plexus|2008-2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|542904382|Male|Choroid plexus|2008-2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|109537622|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109537622|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|109891392|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109891392|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|111265796|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111265796|Male|Choroid plexus|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|180|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|186|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|191|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|196|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|967|542904382|Male|Craniopharyngioma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|542904382|Male|Craniopharyngioma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|196|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|195|109537622|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537622|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|181|109891392|Male|Craniopharyngioma|2011|0.1|0.2|0.2
20+|~|~|~|Malignant|~|109891392|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|203|111265796|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111265796|Male|Craniopharyngioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|142|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|184|105697783|Male|Diffuse astrocytoma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|207|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|542904382|Male|Diffuse astrocytoma|2008-2012|~|~|~
20+|0.1|0.2|0.2|Malignant|840|542904382|Male|Diffuse astrocytoma|2008-2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537622|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|186|109537622|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109891392|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|135|109891392|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111265796|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|112|111265796|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|97|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|95|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|542904382|Male|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|587|542904382|Male|Embryonal/primitive/medulloblastoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537622|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109537622|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109891392|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|109891392|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111265796|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|91|111265796|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|140|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|157|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|733|542904382|Male|Ependymoma variants|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|542904382|Male|Ependymoma variants|2008-2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|145|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|109537622|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109537622|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|109891392|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109891392|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|111265796|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111265796|Male|Ependymoma variants|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|296|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|298|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|285|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|284|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|319|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|28|542904382|Male|Ependymoma/anaplastic ependymoma|2008-2012|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1555|542904382|Male|Ependymoma/anaplastic ependymoma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|328|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109537622|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|319|109537622|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109891392|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|285|109891392|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111265796|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|311|111265796|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|52|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|133|542904382|Male|Germ Cell Tumors|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|241|542904382|Male|Germ Cell Tumors|2008-2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|109537622|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109537622|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|109891392|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|56|109891392|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|111265796|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|111265796|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5471|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.4|5.7|5.6|Malignant|5517|103190694|Male|Glioblastoma|2005|5.2|5.5|5.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5505|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5802|105697783|Male|Glioblastoma|2007|5.3|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.6|Malignant|5983|106947980|Male|Glioblastoma|2008|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|542904382|Male|Glioblastoma|2008-2012|~|~|~
20+|5.5|5.6|5.5|Malignant|30489|542904382|Male|Glioblastoma|2008-2012|5.6|5.7|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.5|Malignant|5988|108197539|Male|Glioblastoma|2009|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|109537622|Male|Glioblastoma|2010|~|~|~
20+|5.3|5.6|5.5|Malignant|6072|109537622|Male|Glioblastoma|2010|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|109891392|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.6|5.5|Malignant|6191|109891392|Male|Glioblastoma|2011|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|111265796|Male|Glioblastoma|2012|~|~|~
20+|5.4|5.7|5.5|Malignant|6402|111265796|Male|Glioblastoma|2012|5.6|5.9|5.8
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|423|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|439|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|440|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|452|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.5|Malignant|465|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|67|542904382|Male|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2221|542904382|Male|Glioma malignant, NOS|2008-2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|439|108197539|Male|Glioma malignant, NOS|2009|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109537622|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|401|109537622|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109891392|Male|Glioma malignant, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|466|109891392|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|111265796|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|460|111265796|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|0.2|0.3|0.2|Benign/Borderline|241|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|281|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|274|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|251|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|287|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|1366|542904382|Male|Hemangioblastoma|2008-2012|0.2|0.3|0.3
20+|~|~|~|Malignant|~|542904382|Male|Hemangioblastoma|2008-2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|268|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|296|109537622|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109537622|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|259|109891392|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|109891392|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|263|111265796|Male|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|111265796|Male|Hemangioblastoma|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|132|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|187|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|104488268|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|259|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|313|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2065|542904382|Male|Hemangioma|2008-2012|0.4|0.4|0.4
20+|~|~|~|Malignant|~|542904382|Male|Hemangioma|2008-2012|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|407|108197539|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|417|109537622|Male|Hemangioma|2010|0.3|0.4|0.4
20+|~|~|~|Malignant|~|109537622|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|469|109891392|Male|Hemangioma|2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|109891392|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|461|111265796|Male|Hemangioma|2012|0.4|0.5|0.4
20+|~|~|~|Malignant|~|111265796|Male|Hemangioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|24|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|34|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|542904382|Male|Local Extensions from Regional Tumors|2008-2012|~|~|~
20+|0.0|0.0|0.0|Malignant|136|542904382|Male|Local Extensions from Regional Tumors|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|29|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537622|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|28|109537622|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109891392|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|109891392|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111265796|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|111265796|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|747|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|773|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|757|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|733|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|771|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|542904382|Male|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
20+|0.7|0.7|0.7|Malignant|3789|542904382|Male|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|756|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109537622|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|754|109537622|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109891392|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|791|109891392|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|111265796|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|737|111265796|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|5.0|5.3|5.1|Benign/Borderline|4784|101938779|Male|Meningioma|2004|4.6|4.8|4.7
20+|0.2|0.2|0.2|Malignant|168|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.4|5.8|5.6|Benign/Borderline|5321|103190694|Male|Meningioma|2005|5.0|5.3|5.2
20+|0.1|0.2|0.2|Malignant|156|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.7|6.1|5.9|Benign/Borderline|5719|104488268|Male|Meningioma|2006|5.3|5.6|5.5
20+|0.1|0.2|0.2|Malignant|149|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.8|6.1|5.9|Benign/Borderline|5878|105697783|Male|Meningioma|2007|5.4|5.7|5.6
20+|0.1|0.2|0.2|Malignant|177|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.2|6.5|6.3|Benign/Borderline|6414|106947980|Male|Meningioma|2008|5.9|6.1|6.0
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.3|6.5|6.4|Benign/Borderline|33543|542904382|Male|Meningioma|2008-2012|6.1|6.2|6.2
20+|0.1|0.1|0.1|Malignant|687|542904382|Male|Meningioma|2008-2012|0.1|0.1|0.1
20+|6.5|6.9|6.7|Benign/Borderline|6869|108197539|Male|Meningioma|2009|6.2|6.5|6.3
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.3|6.6|6.5|Benign/Borderline|6787|109537622|Male|Meningioma|2010|6.0|6.3|6.2
20+|0.1|0.1|0.1|Malignant|117|109537622|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.3|6.6|6.4|Benign/Borderline|6872|109891392|Male|Meningioma|2011|6.1|6.4|6.3
20+|0.1|0.1|0.1|Malignant|136|109891392|Male|Meningioma|2011|0.1|0.1|0.1
20+|6.0|6.3|6.2|Benign/Borderline|6740|111265796|Male|Meningioma|2012|5.9|6.2|6.1
20+|0.1|0.1|0.1|Malignant|136|111265796|Male|Meningioma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|287|101938779|Male|Mixed glioma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|330|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|361|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|343|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|328|106947980|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|542904382|Male|Mixed glioma|2008-2012|~|~|~
20+|0.3|0.3|0.3|Malignant|1712|542904382|Male|Mixed glioma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|385|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109537622|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|340|109537622|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109891392|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|351|109891392|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111265796|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|317|111265796|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|0.5|0.6|0.5|Benign/Borderline|498|101938779|Male|Neoplasm, unspecified|2004|0.4|0.5|0.5
20+|0.6|0.8|0.7|Malignant|618|101938779|Male|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|619|103190694|Male|Neoplasm, unspecified|2005|0.6|0.6|0.6
20+|0.6|0.7|0.7|Malignant|608|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|605|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|575|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|583|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|572|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|589|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|624|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|3052|542904382|Male|Neoplasm, unspecified|2008-2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Malignant|3006|542904382|Male|Neoplasm, unspecified|2008-2012|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|599|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|645|108197539|Male|Neoplasm, unspecified|2009|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|629|109537622|Male|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|590|109537622|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|595|109891392|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|602|109891392|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|648|111265796|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.5|0.6|0.5|Malignant|570|111265796|Male|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|2.1|2.3|2.2|Benign/Borderline|2252|101938779|Male|Nerve sheath, benign and malignant|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2605|103190694|Male|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2561|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2623|105697783|Male|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2580|106947980|Male|Nerve sheath, benign and malignant|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|13246|542904382|Male|Nerve sheath, benign and malignant|2008-2012|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|108|542904382|Male|Nerve sheath, benign and malignant|2008-2012|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2696|108197539|Male|Nerve sheath, benign and malignant|2009|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2644|109537622|Male|Nerve sheath, benign and malignant|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|21|109537622|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2618|109891392|Male|Nerve sheath, benign and malignant|2011|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|16|109891392|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2754|111265796|Male|Nerve sheath, benign and malignant|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|26|111265796|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|542904382|Male|Neuroepithelial|2008-2012|~|~|~
20+|0.0|0.0|0.0|Malignant|119|542904382|Male|Neuroepithelial|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|23|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537622|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109537622|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109891392|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109891392|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111265796|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|26|111265796|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|156|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|183|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|191|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|208|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1004|542904382|Male|Neuronal/glial, neuronal|2008-2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|98|542904382|Male|Neuronal/glial, neuronal|2008-2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|212|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|221|109537622|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537622|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|173|109891392|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|109891392|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|196|111265796|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|111265796|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|470|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|434|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|455|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|431|105697783|Male|Oligodendroglioma|2007|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|391|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|542904382|Male|Oligodendroglioma|2008-2012|~|~|~
20+|0.4|0.4|0.4|Malignant|2071|542904382|Male|Oligodendroglioma|2008-2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|459|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109537622|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|452|109537622|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109891392|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|426|109891392|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111265796|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|353|111265796|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|81|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|414|542904382|Male|Other mesenchymal|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|189|542904382|Male|Other mesenchymal|2008-2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|99|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|109537622|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|109537622|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|64|109891392|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|42|109891392|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|111265796|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|111265796|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|542904382|Male|Pilocytic astrocytoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|744|542904382|Male|Pilocytic astrocytoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|136|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537622|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|161|109537622|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109891392|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|165|109891392|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111265796|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|139|111265796|Male|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|86|542904382|Male|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|93|542904382|Male|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537622|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109537622|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|109891392|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|109891392|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|111265796|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|111265796|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|3.2|3.4|3.3|Benign/Borderline|3267|101938779|Male|Pituitary|2004|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.4|3.7|3.6|Benign/Borderline|3584|103190694|Male|Pituitary|2005|3.4|3.6|3.5
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.6|3.9|3.8|Benign/Borderline|3852|104488268|Male|Pituitary|2006|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|4172|105697783|Male|Pituitary|2007|3.8|4.1|3.9
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4558|106947980|Male|Pituitary|2008|4.1|4.4|4.3
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.4|4.5|4.4|Benign/Borderline|24127|542904382|Male|Pituitary|2008-2012|4.4|4.5|4.4
20+|0.0|0.0|0.0|Malignant|59|542904382|Male|Pituitary|2008-2012|0.0|0.0|0.0
20+|4.3|4.6|4.4|Benign/Borderline|4813|108197539|Male|Pituitary|2009|4.3|4.6|4.4
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.3|4.5|4.4|Benign/Borderline|4862|109537622|Male|Pituitary|2010|4.3|4.6|4.4
20+|~|~|~|Malignant|~|109537622|Male|Pituitary|2010|~|~|~
20+|4.3|4.5|4.4|Benign/Borderline|4891|109891392|Male|Pituitary|2011|4.3|4.6|4.5
20+|0.0|0.0|0.0|Malignant|18|109891392|Male|Pituitary|2011|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|5091|111265796|Male|Pituitary|2012|4.5|4.7|4.6
20+|~|~|~|Malignant|~|111265796|Male|Pituitary|2012|~|~|~
20+|12.0|12.4|12.2|Benign/Borderline|11896|101938779|Male|Total|2004|11.5|11.9|11.7
20+|10.6|11.1|10.8|Malignant|10608|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.4|13.8|13.6|Benign/Borderline|13428|103190694|Male|Total|2005|12.8|13.2|13.0
20+|10.6|11.1|10.8|Malignant|10743|103190694|Male|Total|2005|10.2|10.6|10.4
20+|13.7|14.2|14.0|Benign/Borderline|14060|104488268|Male|Total|2006|13.2|13.7|13.5
20+|10.5|10.9|10.7|Malignant|10786|104488268|Male|Total|2006|10.1|10.5|10.3
20+|14.0|14.5|14.2|Benign/Borderline|14581|105697783|Male|Total|2007|13.6|14.0|13.8
20+|10.4|10.8|10.6|Malignant|11003|105697783|Male|Total|2007|10.2|10.6|10.4
20+|14.7|15.2|15.0|Benign/Borderline|15628|106947980|Male|Total|2008|14.4|14.8|14.6
20+|10.5|10.9|10.7|Malignant|11288|106947980|Male|Total|2008|10.4|10.8|10.6
20+|15.1|15.4|15.2|Benign/Borderline|81814|542904382|Male|Total|2008-2012|15.0|15.2|15.1
20+|10.3|10.5|10.4|Malignant|56305|542904382|Male|Total|2008-2012|10.3|10.5|10.4
20+|15.4|15.9|15.6|Benign/Borderline|16553|108197539|Male|Total|2009|15.1|15.5|15.3
20+|10.4|10.8|10.6|Malignant|11331|108197539|Male|Total|2009|10.3|10.7|10.5
20+|15.1|15.5|15.3|Benign/Borderline|16543|109537622|Male|Total|2010|14.9|15.3|15.1
20+|10.1|10.5|10.3|Malignant|11252|109537622|Male|Total|2010|10.1|10.5|10.3
20+|14.9|15.4|15.1|Benign/Borderline|16538|109891392|Male|Total|2011|14.8|15.3|15.0
20+|10.1|10.5|10.3|Malignant|11374|109891392|Male|Total|2011|10.2|10.5|10.4
20+|14.9|15.4|15.1|Benign/Borderline|16861|111265796|Male|Total|2012|14.9|15.4|15.2
20+|9.8|10.2|10.0|Malignant|11323|111265796|Male|Total|2012|10.0|10.4|10.2
20+|2.1|2.3|2.2|Benign/Borderline|2252|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.1|2.3|2.2
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2605|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|29|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2562|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2624|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2582|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|13257|542904382|Male|Tumors of Cranial and Spinal Nerves|2008-2012|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|108|542904382|Male|Tumors of Cranial and Spinal Nerves|2008-2012|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|2699|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|2645|109537622|Male|Tumors of Cranial and Spinal Nerves|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|21|109537622|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|2621|109891392|Male|Tumors of Cranial and Spinal Nerves|2011|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|16|109891392|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|2756|111265796|Male|Tumors of Cranial and Spinal Nerves|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|26|111265796|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|436|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8929|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|507|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|8.9|9.2|9.1|Malignant|9039|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|8.9|8.8
20+|0.5|0.6|0.5|Benign/Borderline|537|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9147|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|8.9|8.8
20+|0.4|0.5|0.5|Benign/Borderline|506|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.1|9.0|Malignant|9331|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|562|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9576|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.8|9.1|9.0
20+|0.5|0.5|0.5|Benign/Borderline|2877|542904382|Male|Tumors of Neuroepthelial Tissue|2008-2012|0.5|0.5|0.5
20+|8.7|8.9|8.8|Malignant|48020|542904382|Male|Tumors of Neuroepthelial Tissue|2008-2012|8.8|8.9|8.8
20+|0.5|0.6|0.5|Benign/Borderline|570|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.7|9.1|8.9|Malignant|9630|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.7|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|610|109537622|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|9625|109537622|Male|Tumors of Neuroepthelial Tissue|2010|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|559|109891392|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.5|8.8|8.7|Malignant|9671|109891392|Male|Tumors of Neuroepthelial Tissue|2011|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|590|111265796|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.5
20+|8.4|8.7|8.5|Malignant|9732|111265796|Male|Tumors of Neuroepthelial Tissue|2012|8.6|8.9|8.7
20+|3.4|3.6|3.5|Benign/Borderline|3447|101938779|Male|Tumors of Sellar Region|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|19|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|3812|103190694|Male|Tumors of Sellar Region|2005|3.6|3.8|3.7
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|3.8|4.1|3.9|Benign/Borderline|4038|104488268|Male|Tumors of Sellar Region|2006|3.7|4.0|3.9
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.0|4.3|4.2|Benign/Borderline|4363|105697783|Male|Tumors of Sellar Region|2007|4.0|4.3|4.1
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|4754|106947980|Male|Tumors of Sellar Region|2008|4.3|4.6|4.4
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.5|4.7|4.6|Benign/Borderline|25094|542904382|Male|Tumors of Sellar Region|2008-2012|4.6|4.7|4.6
20+|0.0|0.0|0.0|Malignant|60|542904382|Male|Tumors of Sellar Region|2008-2012|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|5009|108197539|Male|Tumors of Sellar Region|2009|4.5|4.8|4.6
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.5|4.7|4.6|Benign/Borderline|5057|109537622|Male|Tumors of Sellar Region|2010|4.5|4.7|4.6
20+|~|~|~|Malignant|~|109537622|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.4|4.7|4.6|Benign/Borderline|5072|109891392|Male|Tumors of Sellar Region|2011|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|19|109891392|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|5294|111265796|Male|Tumors of Sellar Region|2012|4.6|4.9|4.8
20+|~|~|~|Malignant|~|111265796|Male|Tumors of Sellar Region|2012|~|~|~
20+|5.3|5.6|5.4|Benign/Borderline|5106|101938779|Male|Tumors of the Meninges|2004|4.9|5.1|5.0
20+|0.2|0.2|0.2|Malignant|196|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.8|6.1|5.9|Benign/Borderline|5670|103190694|Male|Tumors of the Meninges|2005|5.4|5.6|5.5
20+|0.2|0.2|0.2|Malignant|194|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.1|6.4|6.2|Benign/Borderline|6061|104488268|Male|Tumors of the Meninges|2006|5.7|5.9|5.8
20+|0.2|0.2|0.2|Malignant|181|104488268|Male|Tumors of the Meninges|2006|0.1|0.2|0.2
20+|6.1|6.4|6.3|Benign/Borderline|6212|105697783|Male|Tumors of the Meninges|2007|5.7|6.0|5.9
20+|0.2|0.2|0.2|Malignant|217|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.5|6.8|6.7|Benign/Borderline|6796|106947980|Male|Tumors of the Meninges|2008|6.2|6.5|6.4
20+|0.2|0.2|0.2|Malignant|196|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|6.7|6.8|6.7|Benign/Borderline|35323|542904382|Male|Tumors of the Meninges|2008-2012|6.4|6.6|6.5
20+|0.2|0.2|0.2|Malignant|882|542904382|Male|Tumors of the Meninges|2008-2012|0.2|0.2|0.2
20+|6.9|7.2|7.0|Benign/Borderline|7236|108197539|Male|Tumors of the Meninges|2009|6.5|6.8|6.7
20+|0.2|0.2|0.2|Malignant|197|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|6.6|7.0|6.8|Benign/Borderline|7158|109537622|Male|Tumors of the Meninges|2010|6.4|6.7|6.5
20+|0.1|0.2|0.1|Malignant|150|109537622|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|6.6|6.9|6.7|Benign/Borderline|7195|109891392|Male|Tumors of the Meninges|2011|6.4|6.7|6.5
20+|0.1|0.2|0.2|Malignant|179|109891392|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|6.3|6.6|6.5|Benign/Borderline|7085|111265796|Male|Tumors of the Meninges|2012|6.2|6.5|6.4
20+|0.1|0.2|0.1|Malignant|162|111265796|Male|Tumors of the Meninges|2012|0.1|0.2|0.1
20+|0.6|0.7|0.7|Benign/Borderline|632|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|625|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.8|Benign/Borderline|807|103190694|Male|Unclassified Tumors|2005|0.7|0.8|0.8
20+|0.6|0.7|0.7|Malignant|617|103190694|Male|Unclassified Tumors|2005|0.6|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|832|104488268|Male|Unclassified Tumors|2006|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|586|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|844|105697783|Male|Unclassified Tumors|2007|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|579|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.8|1.0|0.9|Benign/Borderline|905|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|633|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|5126|542904382|Male|Unclassified Tumors|2008-2012|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|3069|542904382|Male|Unclassified Tumors|2008-2012|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1008|108197539|Male|Unclassified Tumors|2009|0.9|1.0|0.9
20+|0.6|0.7|0.7|Malignant|655|108197539|Male|Unclassified Tumors|2009|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1048|109537622|Male|Unclassified Tumors|2010|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|604|109537622|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1066|109891392|Male|Unclassified Tumors|2011|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|620|109891392|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1109|111265796|Male|Unclassified Tumors|2012|0.9|1.1|1.0
20+|0.5|0.6|0.6|Malignant|582|111265796|Male|Unclassified Tumors|2012|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|96|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|110|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|131|104488268|Male|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|119|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|143|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|789|542904382|Male|Unique astrocytoma variants|2008-2012|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|153|542904382|Male|Unique astrocytoma variants|2008-2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|150|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|169|109537622|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109537622|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|166|109891392|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|109891392|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|163|111265796|Male|Unique astrocytoma variants|2012|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|25|111265796|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|144|1120909989|Male and Female|All other|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|108|1120909989|Male and Female|All other|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|226146178|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|226146178|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|226775189|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|226775189|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|229362079|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|37|229362079|Male and Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1233|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1202|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1203|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1197|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1204|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Anaplastic astrocytoma|2008-2012|~|~|~
20+|0.5|0.6|0.5|Malignant|6189|1120909989|Male and Female|Anaplastic astrocytoma|2008-2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1202|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.5|Malignant|1255|226146178|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1254|226775189|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1296|229362079|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|384|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|369|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|350|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|329|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|353|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Anaplastic oligodendroglioma|2008-2012|~|~|~
20+|0.1|0.2|0.1|Malignant|1639|1120909989|Male and Female|Anaplastic oligodendroglioma|2008-2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|323|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|313|226146178|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|316|226775189|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|339|229362079|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1206|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1186|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.5|Malignant|1180|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1150|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1108|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Astrocytoma, NOS|2008-2012|~|~|~
20+|0.4|0.5|0.5|Malignant|5229|1120909989|Male and Female|Astrocytoma, NOS|2008-2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1049|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1067|226146178|Male and Female|Astrocytoma, NOS|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|1007|226775189|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|1013|229362079|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|60|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|73|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|67|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|86|218481776|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|373|1120909989|Male and Female|Choroid plexus|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|1120909989|Male and Female|Choroid plexus|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|72|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|82|226146178|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226146178|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|80|226775189|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226775189|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|229362079|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|229362079|Male and Female|Choroid plexus|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|373|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|410|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|384|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|407|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|416|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2049|1120909989|Male and Female|Craniopharyngioma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1120909989|Male and Female|Craniopharyngioma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|421|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|423|226146178|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226146178|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|391|226775189|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226775189|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|406|229362079|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|229362079|Male and Female|Craniopharyngioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|255|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|293|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|315|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|342|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Diffuse astrocytoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|1500|1120909989|Male and Female|Diffuse astrocytoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|370|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|347|226146178|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|246|226775189|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|203|229362079|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|188|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|169|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|214|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|210|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Embryonal/primitive/medulloblastoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|1000|1120909989|Male and Female|Embryonal/primitive/medulloblastoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|237|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|198|226146178|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|185|226775189|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|173|229362079|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|245|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|266|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|303|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|247|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|254|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1309|1120909989|Male and Female|Ependymoma variants|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|1120909989|Male and Female|Ependymoma variants|2008-2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|256|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|269|226146178|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226146178|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|260|226775189|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226775189|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|274|229362079|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|229362079|Male and Female|Ependymoma variants|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|588|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|598|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|576|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|577|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|629|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|60|1120909989|Male and Female|Ependymoma/anaplastic ependymoma|2008-2012|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|3068|1120909989|Male and Female|Ependymoma/anaplastic ependymoma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|663|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|611|226146178|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226775189|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|578|226775189|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|604|229362079|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|289|1120909989|Male and Female|Germ Cell Tumors|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|286|1120909989|Male and Female|Germ Cell Tumors|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|226146178|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226146178|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|56|226775189|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226775189|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|54|229362079|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|229362079|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9558|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.3|4.5|4.4|Malignant|9665|213511339|Male and Female|Glioblastoma|2005|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9783|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10166|218481776|Male and Female|Glioblastoma|2007|4.6|4.7|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10380|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Glioblastoma|2008-2012|~|~|~
20+|4.4|4.5|4.4|Malignant|53137|1120909989|Male and Female|Glioblastoma|2008-2012|4.7|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10440|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10658|226146178|Male and Female|Glioblastoma|2010|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10723|226775189|Male and Female|Glioblastoma|2011|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.5|4.5|Malignant|11164|229362079|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|843|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|825|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|830|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|855|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|22|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|896|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|111|1120909989|Male and Female|Glioma malignant, NOS|2008-2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4369|1120909989|Male and Female|Glioma malignant, NOS|2008-2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|948|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|226146178|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|797|226146178|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|226775189|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|887|226775189|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|229362079|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|860|229362079|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|443|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|504|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|490|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|461|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|520|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2515|1120909989|Male and Female|Hemangioblastoma|2008-2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1120909989|Male and Female|Hemangioblastoma|2008-2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|495|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|514|226146178|Male and Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226146178|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|490|226775189|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226775189|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|505|229362079|Male and Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|229362079|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|359|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|459|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|530|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|614|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|755|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|4911|1120909989|Male and Female|Hemangioma|2008-2012|0.4|0.5|0.4
20+|0.0|0.0|0.0|Malignant|21|1120909989|Male and Female|Hemangioma|2008-2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|893|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1036|226146178|Male and Female|Hemangioma|2010|0.4|0.5|0.5
20+|~|~|~|Malignant|~|226146178|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1136|226775189|Male and Female|Hemangioma|2011|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226775189|Male and Female|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1095|229362079|Male and Female|Hemangioma|2012|0.4|0.5|0.5
20+|~|~|~|Malignant|~|229362079|Male and Female|Hemangioma|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|51|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Local Extensions from Regional Tumors|2008-2012|~|~|~
20+|0.0|0.0|0.0|Malignant|245|1120909989|Male and Female|Local Extensions from Regional Tumors|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|54|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|50|226146178|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|44|226775189|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|47|229362079|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1341|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1432|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1428|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1368|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1470|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|~|~|~
20+|0.6|0.6|0.6|Malignant|7283|1120909989|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008-2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.6|0.6|Malignant|1418|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1503|226146178|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1502|226775189|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1425|229362079|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|8.6|8.8|8.7|Benign/Borderline|18479|211050944|Male and Female|Meningioma|2004|8.6|8.9|8.8
20+|0.2|0.2|0.2|Malignant|442|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.6|9.8|9.7|Benign/Borderline|20967|213511339|Male and Female|Meningioma|2005|9.7|10.0|9.8
20+|0.2|0.2|0.2|Malignant|432|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.0|10.3|10.2|Benign/Borderline|22317|216055494|Male and Female|Meningioma|2006|10.2|10.5|10.3
20+|0.2|0.2|0.2|Malignant|405|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.2|10.5|10.4|Benign/Borderline|23181|218481776|Male and Female|Meningioma|2007|10.5|10.7|10.6
20+|0.2|0.2|0.2|Malignant|445|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|10.7|11.0|10.9|Benign/Borderline|24786|220975702|Male and Female|Meningioma|2008|11.1|11.4|11.2
20+|0.1|0.2|0.2|Malignant|362|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|10.9|11.0|10.9|Benign/Borderline|128272|1120909989|Male and Female|Meningioma|2008-2012|11.4|11.5|11.4
20+|0.1|0.1|0.1|Malignant|1661|1120909989|Male and Female|Meningioma|2008-2012|0.1|0.2|0.1
20+|11.3|11.6|11.4|Benign/Borderline|26573|223491138|Male and Female|Meningioma|2009|11.7|12.0|11.9
20+|0.1|0.2|0.1|Malignant|350|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|10.8|11.0|10.9|Benign/Borderline|25802|226146178|Male and Female|Meningioma|2010|11.3|11.5|11.4
20+|0.1|0.1|0.1|Malignant|316|226146178|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|10.7|11.0|10.9|Benign/Borderline|25892|226775189|Male and Female|Meningioma|2011|11.3|11.6|11.4
20+|0.1|0.1|0.1|Malignant|313|226775189|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|10.4|10.7|10.6|Benign/Borderline|25710|229362079|Male and Female|Meningioma|2012|11.1|11.3|11.2
20+|0.1|0.1|0.1|Malignant|323|229362079|Male and Female|Meningioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|481|211050944|Male and Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|568|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|631|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|580|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|589|220975702|Male and Female|Mixed glioma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Mixed glioma|2008-2012|~|~|~
20+|0.3|0.3|0.3|Malignant|3010|1120909989|Male and Female|Mixed glioma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|663|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|606|226146178|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|616|226775189|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.2|Malignant|549|229362079|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|0.5|0.6|0.6|Benign/Borderline|1177|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1320|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1480|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1337|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1381|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1302|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1394|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|1227|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1401|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1379|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Benign/Borderline|7074|1120909989|Male and Female|Neoplasm, unspecified|2008-2012|0.6|0.6|0.6
20+|0.5|0.6|0.5|Malignant|6398|1120909989|Male and Female|Neoplasm, unspecified|2008-2012|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1492|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1429|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1420|226146178|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1227|226146178|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1367|226775189|Male and Female|Neoplasm, unspecified|2011|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1226|226775189|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1421|229362079|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1179|229362079|Male and Female|Neoplasm, unspecified|2012|0.5|0.5|0.5
20+|2.1|2.3|2.2|Benign/Borderline|4739|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5338|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5414|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5455|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5487|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.4|2.5|2.5
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|27844|1120909989|Male and Female|Nerve sheath, benign and malignant|2008-2012|2.5|2.5|2.5
20+|0.0|0.0|0.0|Malignant|215|1120909989|Male and Female|Nerve sheath, benign and malignant|2008-2012|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5733|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|5421|226146178|Male and Female|Nerve sheath, benign and malignant|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|43|226146178|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5538|226775189|Male and Female|Nerve sheath, benign and malignant|2011|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|35|226775189|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5748|229362079|Male and Female|Nerve sheath, benign and malignant|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|229362079|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|1120909989|Male and Female|Neuroepithelial|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|240|1120909989|Male and Female|Neuroepithelial|2008-2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226146178|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|48|226775189|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|52|229362079|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|309|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|364|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|374|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|378|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|411|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2089|1120909989|Male and Female|Neuronal/glial, neuronal|2008-2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|199|1120909989|Male and Female|Neuronal/glial, neuronal|2008-2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|427|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|464|226146178|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|226146178|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|404|226775189|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|38|226775189|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|393|229362079|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|229362079|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|819|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.4|Malignant|785|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|827|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.4|Malignant|795|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|742|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Oligodendroglioma|2008-2012|~|~|~
20+|0.3|0.3|0.3|Malignant|3674|1120909989|Male and Female|Oligodendroglioma|2008-2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|810|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|776|226146178|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|727|226775189|Male and Female|Oligodendroglioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|635|229362079|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|147|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|52|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|149|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|152|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|166|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|198|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|94|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|877|1120909989|Male and Female|Other mesenchymal|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|357|1120909989|Male and Female|Other mesenchymal|2008-2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|188|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|169|226146178|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|65|226146178|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|147|226775189|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|226775189|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|177|229362079|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|59|229362079|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|272|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|303|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|302|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|288|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1120909989|Male and Female|Pilocytic astrocytoma|2008-2012|~|~|~
20+|0.1|0.1|0.1|Malignant|1451|1120909989|Male and Female|Pilocytic astrocytoma|2008-2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|269|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226146178|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|324|226146178|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226775189|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|321|226775189|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|229362079|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|255|229362079|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|44|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|47|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|269|1120909989|Male and Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|208|1120909989|Male and Female|Pineal parenchymal|2008-2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|53|226146178|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|226146178|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|56|226775189|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226775189|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|57|229362079|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|229362079|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|3.3|3.4|3.4|Benign/Borderline|7118|211050944|Male and Female|Pituitary|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.7|3.8|3.8|Benign/Borderline|8040|213511339|Male and Female|Pituitary|2005|3.7|3.8|3.8
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.0|4.1|4.1|Benign/Borderline|8805|216055494|Male and Female|Pituitary|2006|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|29|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|9213|218481776|Male and Female|Pituitary|2007|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9911|220975702|Male and Female|Pituitary|2008|4.4|4.6|4.5
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|4.6|4.7|4.7|Benign/Borderline|52648|1120909989|Male and Female|Pituitary|2008-2012|4.7|4.7|4.7
20+|0.0|0.0|0.0|Malignant|114|1120909989|Male and Female|Pituitary|2008-2012|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|10740|223491138|Male and Female|Pituitary|2009|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|21|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|4.6|4.7|4.6|Benign/Borderline|10599|226146178|Male and Female|Pituitary|2010|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|28|226146178|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|4.6|4.7|4.7|Benign/Borderline|10636|226775189|Male and Female|Pituitary|2011|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|28|226775189|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|10931|229362079|Male and Female|Pituitary|2012|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|25|229362079|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|15.7|16.0|15.9|Benign/Borderline|33691|211050944|Male and Female|Total|2004|15.8|16.1|16.0
20+|9.0|9.2|9.1|Malignant|19326|211050944|Male and Female|Total|2004|9.0|9.3|9.2
20+|17.6|18.0|17.8|Benign/Borderline|38358|213511339|Male and Female|Total|2005|17.8|18.1|18.0
20+|9.0|9.2|9.1|Malignant|19624|213511339|Male and Female|Total|2005|9.1|9.3|9.2
20+|18.3|18.7|18.5|Benign/Borderline|40555|216055494|Male and Female|Total|2006|18.6|19.0|18.8
20+|8.9|9.1|9.0|Malignant|19728|216055494|Male and Female|Total|2006|9.0|9.3|9.1
20+|18.7|19.0|18.8|Benign/Borderline|41943|218481776|Male and Female|Total|2007|19.0|19.4|19.2
20+|8.8|9.1|9.0|Malignant|20022|218481776|Male and Female|Total|2007|9.0|9.3|9.2
20+|19.5|19.9|19.7|Benign/Borderline|44588|220975702|Male and Female|Total|2008|20.0|20.4|20.2
20+|8.9|9.1|9.0|Malignant|20453|220975702|Male and Female|Total|2008|9.1|9.4|9.3
20+|19.9|20.1|20.0|Benign/Borderline|231936|1120909989|Male and Female|Total|2008-2012|20.6|20.8|20.7
20+|8.7|8.8|8.7|Malignant|101927|1120909989|Male and Female|Total|2008-2012|9.0|9.1|9.1
20+|20.5|20.9|20.7|Benign/Borderline|47681|223491138|Male and Female|Total|2009|21.1|21.5|21.3
20+|8.8|9.0|8.9|Malignant|20624|223491138|Male and Female|Total|2009|9.1|9.4|9.2
20+|19.7|20.1|19.9|Benign/Borderline|46586|226146178|Male and Female|Total|2010|20.4|20.8|20.6
20+|8.6|8.8|8.7|Malignant|20452|226146178|Male and Female|Total|2010|8.9|9.2|9.0
20+|19.7|20.1|19.9|Benign/Borderline|46757|226775189|Male and Female|Total|2011|20.4|20.8|20.6
20+|8.4|8.7|8.5|Malignant|20363|226775189|Male and Female|Total|2011|8.9|9.1|9.0
20+|19.5|19.9|19.7|Benign/Borderline|47139|229362079|Male and Female|Total|2012|20.4|20.7|20.6
20+|8.3|8.6|8.4|Malignant|20473|229362079|Male and Female|Total|2012|8.8|9.0|8.9
20+|2.1|2.3|2.2|Benign/Borderline|4739|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.3|2.2
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5341|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5416|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|5457|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.3|2.5|2.4|Benign/Borderline|5491|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|49|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|27865|1120909989|Male and Female|Tumors of Cranial and Spinal Nerves|2008-2012|2.5|2.5|2.5
20+|0.0|0.0|0.0|Malignant|215|1120909989|Male and Female|Tumors of Cranial and Spinal Nerves|2008-2012|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5739|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.2|2.4|2.3|Benign/Borderline|5425|226146178|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|43|226146178|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.3|2.4|2.3|Benign/Borderline|5543|226775189|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.4|2.5|2.4
20+|0.0|0.0|0.0|Malignant|35|226775189|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.3|2.4|2.4|Benign/Borderline|5750|229362079|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|51|229362079|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|810|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15964|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.4|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|941|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.4
20+|7.4|7.6|7.5|Malignant|16145|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.4|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1006|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.5
20+|7.3|7.6|7.4|Malignant|16333|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.4|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|976|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|7.4|7.6|7.5|Malignant|16674|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1040|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.5
20+|7.3|7.6|7.4|Malignant|16943|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|5401|1120909989|Male and Female|Tumors of Neuroepthelial Tissue|2008-2012|0.5|0.5|0.5
20+|7.2|7.3|7.3|Malignant|85252|1120909989|Male and Female|Tumors of Neuroepthelial Tissue|2008-2012|7.6|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1067|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.5
20+|7.3|7.5|7.4|Malignant|17180|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1138|226146178|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17133|226146178|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1092|226775189|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.0|7.3|7.2|Malignant|17054|226775189|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.4|7.6|7.5
20+|0.4|0.5|0.5|Benign/Borderline|1086|229362079|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.5
20+|7.0|7.2|7.1|Malignant|17296|229362079|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.4|7.7|7.5
20+|3.5|3.6|3.5|Benign/Borderline|7491|211050944|Male and Female|Tumors of Sellar Region|2004|3.5|3.6|3.5
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.9|4.0|4.0|Benign/Borderline|8450|213511339|Male and Female|Tumors of Sellar Region|2005|3.9|4.0|4.0
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.2|4.3|4.2|Benign/Borderline|9189|216055494|Male and Female|Tumors of Sellar Region|2006|4.2|4.3|4.3
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9620|218481776|Male and Female|Tumors of Sellar Region|2007|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.6|4.7|4.7|Benign/Borderline|10327|220975702|Male and Female|Tumors of Sellar Region|2008|4.6|4.8|4.7
20+|~|~|~|Malignant|~|220975702|Male and Female|Tumors of Sellar Region|2008|~|~|~
20+|4.8|4.9|4.8|Benign/Borderline|54697|1120909989|Male and Female|Tumors of Sellar Region|2008-2012|4.8|4.9|4.9
20+|0.0|0.0|0.0|Malignant|119|1120909989|Male and Female|Tumors of Sellar Region|2008-2012|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|11161|223491138|Male and Female|Tumors of Sellar Region|2009|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|22|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|11022|226146178|Male and Female|Tumors of Sellar Region|2010|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|28|226146178|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|11027|226775189|Male and Female|Tumors of Sellar Region|2011|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|30|226775189|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|11337|229362079|Male and Female|Tumors of Sellar Region|2012|4.9|5.0|4.9
20+|0.0|0.0|0.0|Malignant|25|229362079|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|8.8|9.1|9.0|Benign/Borderline|19069|211050944|Male and Female|Tumors of the Meninges|2004|8.9|9.2|9.0
20+|0.2|0.3|0.2|Malignant|495|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|9.9|10.1|10.0|Benign/Borderline|21620|213511339|Male and Female|Tumors of the Meninges|2005|10.0|10.3|10.1
20+|0.2|0.3|0.2|Malignant|497|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.3|10.6|10.4|Benign/Borderline|22959|216055494|Male and Female|Tumors of the Meninges|2006|10.5|10.8|10.6
20+|0.2|0.2|0.2|Malignant|467|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.5|10.8|10.6|Benign/Borderline|23808|218481776|Male and Female|Tumors of the Meninges|2007|10.8|11.0|10.9
20+|0.2|0.3|0.2|Malignant|522|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.0|11.3|11.2|Benign/Borderline|25504|220975702|Male and Female|Tumors of the Meninges|2008|11.4|11.7|11.5
20+|0.2|0.2|0.2|Malignant|460|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|11.2|11.3|11.2|Benign/Borderline|131664|1120909989|Male and Female|Tumors of the Meninges|2008-2012|11.7|11.8|11.7
20+|0.2|0.2|0.2|Malignant|2026|1120909989|Male and Female|Tumors of the Meninges|2008-2012|0.2|0.2|0.2
20+|11.6|11.9|11.7|Benign/Borderline|27256|223491138|Male and Female|Tumors of the Meninges|2009|12.1|12.3|12.2
20+|0.2|0.2|0.2|Malignant|422|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|11.1|11.3|11.2|Benign/Borderline|26485|226146178|Male and Female|Tumors of the Meninges|2010|11.6|11.9|11.7
20+|0.1|0.2|0.2|Malignant|382|226146178|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|11.0|11.3|11.1|Benign/Borderline|26529|226775189|Male and Female|Tumors of the Meninges|2011|11.6|11.8|11.7
20+|0.1|0.2|0.2|Malignant|385|226775189|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|10.7|11.0|10.9|Benign/Borderline|26392|229362079|Male and Female|Tumors of the Meninges|2012|11.4|11.6|11.5
20+|0.1|0.2|0.2|Malignant|382|229362079|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1541|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1333|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1943|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1352|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1921|216055494|Male and Female|Unclassified Tumors|2006|0.8|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1318|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2014|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1237|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2165|220975702|Male and Female|Unclassified Tumors|2008|0.9|1.0|1.0
20+|0.6|0.6|0.6|Malignant|1402|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|12008|1120909989|Male and Female|Unclassified Tumors|2008-2012|1.1|1.1|1.1
20+|0.5|0.6|0.6|Malignant|6501|1120909989|Male and Female|Unclassified Tumors|2008-2012|0.6|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2388|223491138|Male and Female|Unclassified Tumors|2009|1.0|1.1|1.1
20+|0.6|0.7|0.6|Malignant|1447|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2461|226146178|Male and Female|Unclassified Tumors|2010|1.0|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1249|226146178|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2508|226775189|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|1249|226775189|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2517|229362079|Male and Female|Unclassified Tumors|2012|1.1|1.1|1.1
20+|0.5|0.5|0.5|Malignant|1196|229362079|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|148|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|153|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|177|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|179|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|198|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1145|1120909989|Male and Female|Unique astrocytoma variants|2008-2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|279|1120909989|Male and Female|Unique astrocytoma variants|2008-2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|220|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|233|226146178|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|45|226146178|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|242|226775189|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|55|226775189|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|255|229362079|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|229362079|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
